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SUMMARY 
Squash family protease inhibito rs are small peptides of 27-
32 residues, hence they are ide al subjects for structure-
function studies. Their small size is within the reach of 
peptide chemical synthesis, which enables one to produce 
enough peptide material for expe rimental purposes within a 
reasonabl e time frame. 
A high degree of structural simi larity has been noted 
between squash seeds (Curcurbita maxima) trypsin inhibitor 
(CMTI-I) and carboxypeptidase i nhibitor (CPI) from potatoes 
[1]. For CPI, inhibitory activi t y is located at the carboxy-
terminus whereas in CMTI-I it i s amino-terminus localized. 
Bode et al. [1], proposed that CMTI-I could be elongated on 
the C-terminus to make it a carboxypeptidase inhibitor. 
In separate studies, Le-Nguyen et al. 
chimeric peptide inhibitor consi s ting 
EETI-II (a squash family member) plus 
tetrapeptide of CPI. 
[2] synthesized a 
of the sequence of 
the C-terminal 
In this project, a multispecific inhibitor peptide based on 
the sequence of CMTI-I elongated with the four C-terminus 
residues of CPI was investigated using recombinant DNA 
techniques. The proposed hybrid gene sequence of the 
inhibitor protein was cloned and expressed in the prokaryote 
Escherichia coli and the unicellular eukaryote Pichia 
pastoris (a yeast) . The amount of recombinant product 
produced by the two hosts was compared. In protein 
production, the number of extract i on (purification) steps 
tend to determine the yield of fi nal product. The cost of 
resins and equipment used during t he purification is also a 
factor whi c h must be considered. 
It was found that protein secretion into the medium by P. 
pastoris facilitated purification of the inhibitor peptide, 
and the yields were reasonably good at laboratory scale 
level. On the contrary, expression of the inhibitor peptide 
as a fusion protein destined for translocation into the 
periplasm of E. coli required tedious extractions. The 
purification also necessitated the use of expensive and non 
regeneratable resins. 
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Part 1 
Review On Protease Inhibitors 
1.1 General 
Protease inhibitor proteins are ubiqui t ous in the animal, plant and 
micro-organism kingdoms as they consti t ute an abundant group of 
proteins [3-5] . For example, the blood of higher animals contains 
cumulatively over 200 mg of various protease inhibitor proteins per 
100 ml serum [3]. Storage organs of plan ts such as seeds and tubers, 
contain from 1 to 10% of their proteins as inhibitors of various 
types of proteolytic enzymes [6] and some fruits contain even up to 
50% of their proteins as inhibitors of s erine proteinases [7] . 
There are two groups of proteins/peptides which could be classified 
as inhibitors since they inhibit enzymatic reactions . The first group 
consist of the high molecular weight a 2-macroglobulins which are 
found in plasma of all animals and are a b le to inhibit proteases from 
the four mechanistic classes; i.e., serin e-, cysteine-, aspartyl-, 
and metallo-proteinases. Inhibition is a chieved by means of a 
promiscuous "bait region". The second group is made up of class 
specific proteinase inhibitors. They have reactive sites which offer 
a particular peptide bond, designated P1-P1 1 by the notation of 
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Schechter and Berger [8], as bait to the reactive site of the cognate 
protease. Usually, the nature of the P1 residue determines the 
specificity of the inhibitor. Protease s and proteinase inhibitors 
differ profoundly in the variability o f the active site. Changes in 
the reactive site of an inhibitor alte r specificity but may not 
reduce inhibitory activ ity, whereas variations in the active site of 
an enzyme t e nds to destroy proteolytic activity [9,9a]. 
Class specifi c inhibitors mediate nume r ous physiological processes. 
Inhibitors o f metallo-proteases are not very common. In plants a 
small carboxypeptidase inhibitor (CPI) from potatoes has been studied 
in detail [10] . When fed to newly hatche d chicks the inhibitor was 
not found to be deleterious to their growth at levels in which serine 
proteinase inhibitors from potatoes were toxic [11] . Collagenases are 
the main human metallo-proteinases and are found in leukocytes, the 
plasma, fibroblasts and synovial fluids. The activation of these 
enzymes duri ng an inflammatory response i s controlled by inhibitors . 
If the level o f inhibitor protein is low, rheumatoid arthritis, 
pulmonary emphysema and other cases of tissue degradation may develop 
[12]. Asparta te proteinase inhibitors are also not very common. 
However, in mammals pepsin inhibitors have been reported. In 
addition, r enin i nhibitors have been used in the control of 
hypertension [12] . The cystatin (cysteine proteinase inhibitors) 
super family i s made up of at least three distinct but related 
families of cysteine proteinase inhibitors [13] . Major plasma 
proteins cal led kininogens are known to be involved in the 
inflammatory process, including activation of the intrinsic clotting 
cascade. More recently, it was shown that t hey may also regulate the 
I 
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activity of other cysteine proteases such as cathepsin B, H, and L, 
as well as calpain I and II [14] . Cysteine proteinase inhibitors have 
been found to be active against the enzymes of the picornavirus 
responsible for polio [15] . 
The largest number of class specific proteinase inhibitors belong to 
the serpin (serine) superfamily . They have been isolated and 
characterised from vast sources such as plants and animals including 
micro-organisms. They are grouped into families based on sequence 
similarity, topological similarity and mechanism of binding. The 
following list was compiled by Ryan [1 6 ] . 
Plant 
Squash Inhibitor Family 
Barley Trypsin Inhibitor Family 
Potato II Family 
Potato I Family 
Soybean Proteinase Inhibitor Family (Bowman-Birk) 
Soybean Trypsin Inhibitor Family (Kunitz) 
Animal 
Bovine Pancreatic Trypsin Inhibitor Family 
(Kunitz,Kunin) 
Pancreatic Secretory Trypsin Inhibitor Family 
(Kazal) 
Ascaris I Inhibitor Family 
Chelonianin Family 
I 
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Serpin Family (mechanistically d istinct) 
Hirudin Family 
Micro-organism 
Streptomyces Subtilisin Inhibitor Family 
The broad function of proteinase inhib itors in biological systems is 
to prevent uncontrolled proteolysis within cells, organelles, or 
fluids where limited proteolysis is important for biochemical and 
physiological processes. In so doing t h ey aid in the maturation of 
many enzymes and the activity of numerous fully processed molecules. 
Proteinase inhibitors also protect prot eins of cells, fluids or 
tissues from foreign proteolytic enzyme s. In addition, they are 
implicated in signalling receptor activ ation or clearance. In 
general, the regulation of proteolysis in nature is still not well 
understood since the specific roles of most known proteinase 
inhibitors are not well defined. 
Travis and Salvesen [17] implicated prot einase inhibitors in the 
control of the blood coagulation cascade , fibrinolysis and the 
complement response and in the control o f fertilisation and 
digestion. Eglin c, a potent serine proteinase inhibitor isolated 
from the leech, Hirudo medicinalis, inhibits chymotrypsin,subtilisin, 
and the leukocyte proteinases elastase a n d cathepsin G [18] . Due to 
its multispecificity, it has attracted a t tention as a possible 
therapeutic agent against various pathogenic elastase-like tissue 
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agents, blood c lotting disorders and inflammatory processes. 
Inhibitor deficiency is known to be link ed to the development of 
pulmonary emphysema [19] and plaques whi ch characterise Alzheimer's 
disease contain inhibitors of proteinase s [20]. In plants, proteinase 
inhibitors are ubiquitous and are though t to play a role in the 
defense systems against insect pests and in protein storage 
[21,2la,2lb] 
Proteinase inhibitors prevent access of s ubstrate to proteinase's 
catalytiic sites by steric hindrance. The re are two well documented 
models of protein inhibitor interactions. Small (composed of 27 to 
about 180 amino acids) serine proteinase inhibitors interact with 
substrate in a "substrate-like"(canonical ) mechanism i.e., the 
standard mechanism. Other inhibitors, CPI for example, display 
product-like inhibition. The unravelling o f new crystal structures 
uncovers novel modes of inhibition. For instance, the 
cystatin/stefin-papain complexes and the i n teraction of hirudin with 
thrombin [2lc] implicate modes of interact i on which are only partial 
substrate-like in character. 
In substrate-like binding, intra- and inter -molecular interactions of 
inhibitor primary binding segments with inhibitor cores (through 
spacer elements) and with enzyme active site s mutually stabilize one 
another. Protein inhibitors interacting via this model have a compact 
shape, a hydrophobic core which is often di s ulfide interconnected, 
and a domain segment forms a scaffold for t h e exposed proteinase 
binding loop. The binding loop is flat in s hape and fits into the 
active site of cognate proteinase. Residues from P3 to P3 , (flanking 
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the scissile peptide bond) have a characteristic canonical 
comformation i.e., when analyzed in d ifferent crystal environments 
[22,22a] or complexation states or by NMR techniques in solution 
[23], the same inhibitors exhibit similar confornations. The 
canonical interaction may be represent ed as follows: 
E + I EI E + 
Notation; E- cognate enzyme, I - virgin inhibitor, EI- stable enzyme 
inhibitor complex and I*- modified inhi bitor. 
The EI compl ex is rapidly formed and u s ually dissociates very slowly. 
Note that I* is cleaved at the scissil e peptide bond P1 -P1 1 • 
Interactions of P1 side chain with the specificity pocket of enzyme 
(8 1 subsite ) are energetically the most important, hence are the 
primary determinants of specificity of a given protein inhibitor for 
a particular proteinase. For example, R or K at P1 confer trypsin-
like specifici ty in serine proteinases. A secondary binding segment 
of about 4 r es idues in length is also present but its interactions 
are not very specific. It appears that the relatively rigid inhibitor 
peptide loop does not lose as much confor mational freedom on binding 
as a flexible substrate would, so that t h e enzyme-inhibitor complex 
forms with a favourable, relatively low entropy loss. Coupled with 
the electrostatic and van der Waal's inte ractions between the two 
highly compl ementary structures, this giv es a large and negative free 
energy of association for the formation of the stable complex [24] . 
In product-like binding, the remaining int eractions are strong enough 
to prevent fast dissociation. Take CPA/CP I interactions for an 
illustration . The projecting C-terminus r e sidues (4) of CPI form the 
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primary contact region which inserts into the active site of CPA. 
Glycine 39 is cleaved off but remains buried by the rest of the 
inhibitor moiety. A few secondary contac ts confer stability. The 
primary contact region is flexible, but upon binding it becomes 
rigid. The combination of primary and s econdary contacts keep the 
truncated inhibitor in position i.e., fast dissociation or further 
intrusion into the active site of enzyme is prevented. 
As more new crystal structures of protein inhibitors in complex with 
their proteinases become available new modes of interactions are 
being discovered. The interaction of hirudin with thrombin shows that 
the nucleophilic Serl95 of thrombin is not blocked, nor is its 
specificity pocket used by hirudin residues. It is filled instead 
with several structured water molecules. The globular domain of 
hirudin contacts characteristic thrombin surface patches adjacent to 
the thrombin active site. 
1.2 Protease Inhibitors In Plants 
1.2.1 Background 
Inhibitors of proteolytic enzymes are found in large proportions in 
vulnerable plant tissues such as floral organs, seeds, tubers and 
some fruits. In particular, they have been isolated in members of the 
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Leguminoseae, Graminaceae, Liliacea, Solanaceae and Curcurbitaceae 
families. Plant protein inhibitors tend to be small in molecular 
mass; typically within the range 3Kda to 50Kda. In general, they act 
as regulatory agents that control endogenous enzymes and the 
degradation of storage proteins during seed maturation. Inhibitor 
peptides also play a role as protective agents against pest and 
pathogens attacking plants. 
1.2.2 Protease Inhibitor Families In Plants 
In plants, a total of about ten protease inhibitor families has been 
identified and most are specific for serine proteinases [25) . Ryan 
[26) tabulated the following list: 
1. Soybean Trypsin Inhibitor (Kunitz) Fa mily 
2. Bowman-Bi r k Inhibitor Family 
3 Barley Trypsin Inhibitor Family 
4. Potato Inhibitor I Family 
5. Potato Inhibitor II Family 
6. Squash Inhibitor Family 
7. Ragi 1-2 /Maize Bifunctional Inhibitor Family 
8. Carboxypeptidase A, B Inhibitor Family 
9. Cysteine Proteinase Inhibitor Family (Cystatins) 
10. Aspartyl Proteinase Inhibitor Family 
The first sev en are serine protease inhibitors and the last three 
9 
include families that are specific for either cysteine, aspartyl , or 
metallo-classes of proteases . 
1.2.3 Effects Of Plant Protease Inhibitors On The 
Digestive Processes Of Insec t s And Higher Animals 
Animals require proteolytic enzymes to degrade macromolecules such as 
proteins into simpler components which could be absorbed by their 
intestines . In mammals digestion i s achieved extracellularly in 
organs such as the stomach, intestines, rumen or midgut. Numerous 
microbes use the extracellular digestion strategy by secreting 
hydrolytic enzymes into the surround ing environment. The resulting 
monomeric (oligomeric) amino acids a re then taken up. 
Since proteases play an important r o le in the digestive physiology of 
vertebrates and insects, considerabl e focus has been directed at the 
effects of protease inhibitors which are often present in food. For 
humans, protease inhibitors do not p ose any problems because foods 
which contain a high concentration o f inhibitors are cooked, thus 
inactivating the inhibitor proteins. In 1917 it had been noticed that 
soybeans would not support growth of rats unless cooked for several 
hours. Later (1940) Kunitz and Bowman discovered that beans contain 
trypsin inhibitors. 
The adverse effects of inhibitors of proteolytic enzymes in foods are 
very complex. Inhibitors do not only reduce the proteolytic 
• I 
I' 
I 
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activities of digestive hydrolytic enzymes; it was observed that when 
trypsin inhibitors are added to artif i cial diets of rats they 
stimulate pancreatic secretion to abov e normal levels [27) . This 
implicates the involvement of trypsin in the regulation of pancreatic 
secretions. The regulation involves t h e degradation of a 'monitor' 
peptide which is released into the gut where it regulates secretion 
of cholecystokinin (CCK) , a circulating polypeptide hormone [28) . It 
appears that the interaction of inhibitors with trypsin and other 
proteases interferes with normal proces sing of the monitor peptide, 
which then abnormally stimulates a comp lex feedback mechanism that 
leads to chronic physiological response s in animals. Consequently, 
the presence of protein inhibitors in l arge concentrations can lead 
to hypersecretion by pancreatic tissues , loss of proteolytic activity 
in the gut, loss of appetite, starvation and eventual death. 
There is no direct evidence to indicate the presence of CCK-like 
hormones in insects. However, insects mi ght have feedback mechanisms 
which control protease production. For example, Baker et al. [29) 
showed that the secretion of hydrolytic enzymes in insect guts 
depends upon midgut protein content and not food volume. Protease 
secretion regulation may be attributed t o two mechanisms which might 
not be mutually exclusive; involving ei t her direct effects of food 
components on midgut epithelial cells, o r a hormonal effect which is 
triggered by food ingestion [30) . Larvae of Heliothis zea and 
Spodoptera fed on artificial diets supplemented with soybean trypsin 
inhibitor (SETI) plus potato Inhibitor II experienced elevated 
trypsin-like activities in their digestiv e tracts [31) . This is 
similar to the negative feedback of highe r animals mentioned earlier . 
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1.2.4 The Use of Protease Inhibitors As Defensive 
Proteins Against Plant Pests And Pathogens 
Man's need to produce more food on arable soils which are being 
eroded each y e ar has necessitated the development of new crop 
breeding methods and protection strat egies. Numerous plants have been 
modified by breeding and selection t o the extent that they are nearly 
unrecognizable with respect to their native progenitors. Recombinant 
DNA techniques have speeded up genet i c modification of agronomically 
important crops. The plants are grown in new, often hostile 
environments where they become prey t o predators and pathogens 
against whom they have not evolved s u itable counter measures. 
Moreover, insects, viruses and other pathogens have been transported 
far from the ir native habitats . This presents the pathogens and 
insects with new prey species. 
The threat o f pathogens and pests on c rop yields led to the 
development of agrochemicals. The exc l usive use of chemical 
pesticides has resulted in rapid build -up of resistance to such 
chemicals (3 2 ) . Insecticides tend to b e non-selective therefore 
disturb the balance between pests and natural predators. Some 
pesticides being non-biodegradable, a c cumulate in the foodchain 
causing serious environmental conseque nces and concerns for human 
health (33) . 
One alternative to the use of agrochemicals would require the 
exploitation of resistant plant variet ies which includes the use of 
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genetically engineered insect-resistant crops. Neurath (34] proposed 
that primitive organisms accompli s hed control of proteolysis by means 
of protease inhibitors. Plant tissues are very rich in protease 
inhibitors which could interact with pests and pathogens that attempt 
to consume them (35] . The serine inhibitor family has been isolated 
and characterised from plants more frequently than cysteine-, 
metallo-, and aspartyl-proteinase inhibitors. Numerous studies 
concerning the possible role of cys teine and serine proteinase 
inhibitors in natural plant defense systems have been done. It should 
be specified that the defensive ro l e of proteinase inhibitors is only 
part of a complex interaction betwe en the many defensive chemicals 
that are present or induced in plants and predators and pathogens 
that attack them (36,37]. Inducible chemicals which occur 
constitutively include antibiotics , alkaloids, terpenes and proteins 
in the form of enzymes, lectins and enzyme inhibitors. Upon pathogen, 
pest or mechanical wounding, a plan t initiates production of the 
defensive chemicals mediated by pot ential signals. The signals could 
be oligosaccharides derived from t h e cell wall of pathogens, insects 
and the plant themselves [38]; lipids such as eicosapentanoic and 
arachidonic acid (39) ; action poten tials [40] ; abscissic acid [41) ; 
phytoalexins [42]; or hormones such as indole-3-acetic acid (IAA) 
[43]. Recently, the peptide systemin [44,45] as well as salicylic 
acid have been shown to be signal molecules in the systemic induction 
of defenses in response to wounding. Induced chemicals are mostly the 
product of complex biochemical pathways whose components are encoded 
by many genes. Some, are under control of single genes. Single genes 
which code for inducible proteins have practical advantages since 
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they could be i solated and transferr ed from one species to another . 
Many protease inhibitors are product s of single genes [46) . 
In considering the capability of any proteinase inhibitor in a plant 
tissue to i nhi bit a foreign protease which is released into the 
digestive t ract of a herbiv ore or s e creted by a micro- o rgani s m, t h e 
mechanisti c c l a ss and peptide bond s pecificity of the protease must 
be known. Structural aspects of the inhibitor that determine its 
ability to i n teract specifically wi t h a particular enzyme should also 
be evaluate d. In addition , the assoc iation constant of the 
interaction between protease and inh ibitor should be of sufficient 
strength. Typically, association constants ranging from 106 to 1010 
(M-1 ) and some times higher have been reported [3] . These 
considerations require a better unde rstanding of the digestive 
physiology of insects and the effec t s of protease inhibitors on these 
processes. A knowledge of proteases present in midguts of insects is 
also crucial . In the order Lepidopte ra, which encompasses numerous 
crop pests , t he pH in the gut is in the alkaline range of 9 to 11 
where serine proteinases and metallo exopeptidases are most active 
[30) . As a r e sult, these herbivores should be targeted with serine -
and metallo -proteinase inhibitors. Serine proteinases have been s hown 
to have antinutritional effects against several lepidopteran insects 
[47-49) . 
In the case of several families in t he orders Hemiptera and 
Coleoptera, cysteine proteinases are the main enzymes which appear to 
play a role in the digestion of food proteins. The midguts of these 
insects are c haracterised by mildly acidic pHs which are near the pH 
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optimum of cysteine proteinases (pH-S) . Most coleopteran insects are 
seed- and leaf-eaters hence they are ma jor crop pests. Serine 
proteinases have not been identified i n coleopteran pests. Thus, 
larvae of the coleopteran cowpea weevil can consume cowpea tissues, 
which are rich in serine proteinases, without any adverse effects on 
digestion [SO]. Similarly, the larvae o f colorado potato beetle 
(another coleopteran) can readily consume potato and tomato tissues 
[Sl] . It should be clear that cysteine proteinase inhibitors are the 
best defense candidates to obstruct digestion of plant proteins in 
Coleoptera and Hemiptera insect pests . 
1.2.4.1 Indirect Evidence For The Successful Use Of 
Protease Inhibitors As Growth Inh ibitors 
In the 19SO's Lipke et al. [S2] showed t hat fractions from soybeans 
inhibited growth as well as proteolytic activity in vitro of the 
mealworm, Tribolium confusum. Likewise, the growth of Tribolium 
casteneum larv ae was affected b y purifie d fractions of soybean 
proteins which were added to artif~cial diets [S3] . Moreover, 
purified bowman-birk trypsin inhibitor (EETI) at S% of diet inhibited 
growth of the same larvae [S4] . 
Diets containing a combination of protea se inhibitors unearthed more 
facts on the subject. Soybean trypsin inhibitor (SETI) mixed with 
inhibitors of bovine trypsin when fed to larvae of european cornborer 
at 2-S% of diets showed that only the SETI inhibited growth and 
delayed pupation [SS] . The corn inhibitors on their own had no 
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effects on growth or pupation. Broadway and Duffer [33] investigated 
the effects of SBTI and potato Inhib itor II (anti trypsin and 
chymotrypsin) on the growth and dige stive physiology of larvae of H. 
zea and S. exigua. At a level of about 10% in the diets, growth of 
the larvae was hindered. The addition of methionine to the diets 
reversed the adverse responses. It was concluded that the inhibition 
of protein digestion alone did not only cause the adverse effects but 
also resulted in hyperproduction of digestive enzymes which enhanced 
the loss of sulphur amino acids by the insects. 
The blood sucking insect (Haematobia irritans L.) when fed blood 
containing 0 . 02% (w/v) leupeptin or 0 . 1% (w/v) SBTI showed a 
reduction in fecundity [56] . In addition, the stable flies (Stomaxys 
calcitrans ) raised on SBTI encapsulated in erythrocytes failed to 
produce eggs and a 50% mortality was observed. 
1.2.4.2 Direct Tests On Roles Of Protease Inhibitors In 
Plant Leaves To Def end Agains t Pests 
The first results were reported by Hilder et al. [SB]. Transgenic 
I 
tobacco expressing a foreign cowpea tyrpsin inhibitor (CpTI) I 
accumulate d this inhibitor peptide at relatively high level (1%) . He 
noticed that the transgenics were more resistant to feeding by larvae 
of Heliothis virescens than untransformed control plants or plants 
that did not express the gene . Cowpea trypsin inhibitor is an 
antinutrient against a wide range of insects [SO], such as Heliothis, 
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Spodoptera, Diabrotica, and Tribolium. All are agronomically 
important pests . 
Johnson et al [59) transformed tobacc o plants with a gene coding for 
tomato and potato Inhibitor II (havin g trypsin and chymotrypsin 
inhibitory activities) . Other tobacco plants were transformed with a 
gene coding for tomato Inhibitor I (having chymotrypsin inhibitory 
activity). In both groups of plants, the regulation of expression was 
under control of the constitutive cau liflower mosaic virus (CaMV) 
promoter. Leaves expressing Inhibitor II protein at 50 µg/g tissue or 
above caused severe growth inhibition of Manduca sexta larvae growth. 
Larvae feeding on native control plants were unaffected. In addition, 
plants expressing Inhibitor II at 10 0 µg/g leaf tissue caused larvae 
to grow even less and some died. On t he contrary, larvae feeding on 
leaves containing Inhibitor I at leve ls greater than 100 µg/g leaf 
tissue were not affected. The result s indicate that trypsin-inhibitor 
activity of Inhibitor II was largely responsible for the adverse 
effects on insect growth. 
Recently, it has been demonstrated that an array of inhibitors of 
proteases such as trypsin, chymotryps in, elastase, carboxypeptidase 
and even toxins acting in concert may add to defensive potentials of 
plant tissues. Mcintosh et al. (1990 ) [60) illustrated in feeding 
trials with H.virescens that a fusion protein comprising Bacillus 
thuringiensis var. kurstaki HD-1 prot ein fused to a squash trypsin 
inhibitor (CMTI) potentiated subletha l concentrations of the Bt 
protein alone. Clearly, numerous aspe cts of proteinase inhibitor 
functions are not fully understood. Boulter (1990) [61) used progeny 
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whose transgenic parents expressed e i ther the CPTI gene or a pea 
lectin gene. Progeny that inherited a nd expressed both genes 
demonstrated an enhanced resistance t o H. virescens when compared to 
plants that expressed either one of t he two genes. This 
multifunctional approach closely rese mble the situation in nature. 
Finally, a gene which could be useful in this approach is that of 
cathepsin D. The product of the gene is capable of inhibiting 
trypsin, chymotrypsin and cathepsin D. 
1.2.4.3 Protease Inhibitors As Likely Defense Agents 
Against Plant Pathogens 
During the nineteenth century the fungus, Phytophthora infestans, 
caused widespread famine and waves o f migration from Ireland and 
other european countries. The discove ry of fungicides brought the 
disease caused by the fungus in plant s under control. Bacterial plant 
diseases are still a problem and w~ have to find an alternative to 
the copper sulfate treatment in order to reduce expenses and possible 
environmental costs. 
Only indirect evidence for the involv ement of protease inhibitors in 
the control of microbes has emerged. The availability of transgenic 
plants expressing foreign proteinase inhibitor genes should allow 
direct testing. Peng and Black [62] s howed that levels of trypsin 
inhibitor increased in leaves in vari eties of tomato that were 
resistant to phytophthora infestans over those found in susceptible 
varieties. An increase in proteinase inhibitory activity in melon 
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plants infected with Colletotrichum l indemuthianum or treated with an 
elicitor from this organism was noted by Roby et al . [63]. 
Suspension-cell cultures of tobacco t reated with elicitor obtained 
from phytophthora parasitica showed a n increased proteinase inhibitor 
synthesis [64] . Activities of protein ases from Fusarium solani [65] 
and C. lindemuthianum [66] were reduc ed by proteinase inhibitors 
isolated from healthy bean and tomato plants. It was also proven that 
a cocktail o f proteinase inhibitors i solated from potato tubers [67], 
green tomato fruits [68] , and pumpkin reduced growth of microbes 
present in s poiled tissues of these o rgans . Presumably, proteolysis 
of protein substrates by enzymes sec r eted by the micrograms was 
limited. 
Inhibitors directed against microbial proteinases are present in 
plants, especially legumes. For examp le, inhibitors of the serine 
class of enzymes secreted by Bacillus subtilis are common in seeds or 
vegetative tissues of legumes, cereals and tuberous crops [69]. 
Inhibitors of subtilisins have been identified in at least three of 
the inhibito r families i . e., potato inhibitor I family, the kunitz 
family and the cereal/amylase inhibitor family. 
1.2.4.4 Difficulties With The Use Of Protease Inhibitors 
Numerous strategies for cloning genes into genomes of dicotyledons 
are available, but some monocotyledonous plant species have turned 
out to be difficult to transform. The successful strategies include: 
differential expression with respect to genotype, tissue-specificity 
19 
or physiological conditions; transposon tagging; biochemical 
characterisation of binding sites for r a ce-specific elicitors; and 
shotgun cloning. Sucking pests such as a phids do not rely on 
proteolysis for digestion and therefore do not appear to have 
digestive proteases. They depend on fre e amino acids in the phloem as 
a nitrogen source . For a given insect s p ecies, some inhibitors are 
found to be effe ctive antimetabolites whereas others are not. In 
addition, adaptations in the type of enzyme used for digestion by 
insects have been observed; seed weevil s feeding on plant tissues 
rich in inhibitors of serine proteinases have replaced these 
digestive enzymes with a thiol protease [50,70]. The identification 
and isolation o f genes that can improve crop yields is still in its 
infancy. A good deal remains to be learned of the fundamental 
biochemistry, phy siology and molecular biology of plant processes and 
of plant interactions with their environments. It should also be 
noted that no proteinase inhibitor teste d is as effective against any 
pest as are agrochemicals and toxins. 
Part 2 
Design of a chimeric Protease Inhibitor 
Availability of crystal structures of p r oteinaseas in complex with 
their inhibitors has allowed the design of several inhibitors. CPI 
and CMTI are competitive protein inhibi t ors which bind tightly to the 
active site of cognate proteinases. 
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The structure of CMTI has been solved in complex by X-ray analysis 
[71] and in solution by NMR [72]. Similarly, the structure of CPI has 
been studied in solution using NMR [73] and by X-ray crystallography 
in complex with CPA [74] . The structure co-ordinates of both 
complexes have been deposited in the Bro okhaven databank. Thus, 
molecular modelling was conducted by a knowledge based approach i . e., 
using the nativ e structures as a startin g point [75] . 
The aim was to produce a hybrid structur e that retained the crucial 
structural aspects of booth CMTI and CPI . Computer modelling was 
conducted using the BIOGRAF program (Biodesign, Pasadena, USA) on an 
Evans and Sutherland workstation. 
2.1 Topological Similarity of CMTI and CPI 
The structures of CMTI and CPI were aligned on the workstation on the 
basis of the l east squares fit to the distances between the cysteine 
alpha carbons; a root mean square (rms) deviation reported by Bode et 
al. [71], of 1 . 82A, was obtained. 
Crucial features which were observed are as follows: 
a. The backbones of the two structures f ollow the same path in space, 
Figure 1 and Figure 2. 
b . The disulphide pairing is identical i n the two molecules i.e., the 
three cysteine residues of the amino ter minal half are connected with 
those of the carboxy terminal half in identical spatial relationship . 
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Fig. 1. Ca. drawing of the superimposed backbones of CPI (yellow) and CMTI (white). 
101 101 
Figure 2. Stereo view on the alignment of the two backbones. CPI in bold 
lin es and CMTI in thin lines. From reference 1. 
Rvt;~~~~~~;;~~~F==~~;2-v5L-EHGYCG L _____ [________ j 
---------------
Fig. 3. Alignment of the amino acid sequences of CPI and CMTI indicatina 
b 
the identical disulfide pairing. 
The disulphide bridges are shown in Figur e 2. They contribute to a 
core around whi c h the rest of the mol e cul e is folded. The fi rst two 
disulphide bridges are of right-handed whereas the third one i s o f 
left-handed conforma tion . 
c. The active si tes of the inhibitors are isolated; for CPI, the 
C-terminus is t h e exopeptidase binding site while the NH2 -terminus o f 
CMTI provides the endopeptidase binding s ite. 
The alignment of the sequences of CMTI a n d CPI is d e pi c ted in Fi g u re 
3. The two peptides share only 4 identica l residues besides the six 
cysteines. 
Topological similarity suggests a common evolutionary origin for the 
two peptides. The globins are another series of proteins which show a 
high degree of s tructural homology. In s uch proteins, many mutations 
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to the primary sequence could be tolerated without any serious defect 
in function. 
2.2 Natural Variants Of CMTI And CPI 
A search through the protein sequence data bank yielded numerous 
analogues of CMTI-I which are displayed in Figure 4. It is evident 
that the residues located at the reactive site (P1 ), the disulfide 
bonds and the COOH termini are complete ly conserved in all the squash 
family inhibitors. The exception is the bitter gourd inhibitor 
(MCEI-III) whose reactive site is direc ted against elastase. 
CPI has an analogue in the tomato plant , carboxypeptidase inhibitor 
from tomato fruit (CTI). See Figure 4 f or the alignment of the 
sequences of CPI and CTI. 
The alignment of the natural sequences enables us to pinpoint 
mutations which could be tolerated beca use there is flexibility in 
the primary structures. 
TGT I · l 
TGT I · I 
TTI · I 
TT I · I 
ID.ff! 
MCT I · l 
MCTI · I 
MCEI · I 
CMT I · I 
CMTI· m 
CllTI - IV 
CPGTI · I 
CPT I · I 
CPT I · m 
CST I - I 
CSTI - IV 
EET I· I 
CVT I - I 
Bill I · I 
(To•cl gourd( 
!T o•el gourd! 
(T r icbo11cithnl 
I Tri ch o 11otbr1 } 
(llami me I oo ) 
(Biller gourd! 
(Biller gourd! 
(Bi tter rourdl 
(S quub) 
(Squa ab) 
I 0 11 20 JO 
CPR LllPCSSDSDCLAECICLEN GFCG 
G CPR l.MPCKTUDDCM L DCRCl.SN GYCG 
C P R LMPCKVNUUCLRGCKCLSN GYCG 
C P R 
V G C P R 
ERRCPR 
R I C P R 
R I C P L 
R V C P R 
R V C P R 
LMPCQVNDUCLRGCKCLSN GYCG 
LMKCKTDDDCLLGCKCLSN · GYCG 
LKQCKRDSDCPGEC CMAI GfCG 
fMECKROSDCMAQCICVD GJICG 
WMECKRDSDCLAQCICVD GJICG 
LMECKKDSDCl.AECVCLE GYCG 
l.llKCKKDSDCLAECVCLE GYCG 
(Squ ub l JIEERVCPR LMKCKKOSOCLACCVCLE GYCG 
!Zuccbioll RVCPK LMECKKDSDCLAECICl.E GYCG 
JSu lllll>er 1qu11b l RV C PK L MECK K 0 SD CL A CC I C LE G Y CG 
(S ull\ll) er 1qu11b l JI EE RV C PK I. M !: CK K 0 S II CL A EC I r. L E G Y CG 
(Cucumber! M V C PK L MK CK JIU S II C I. L II CV CL C II G Y CG VS 
(C uc umber! M M C P R 0 II K C K II D S D C L P G C V C L E JI C Y C G 
(Ecballiumclateriuml GCPR LMRCKQOSDCLAGCVCGPN GfCGSP 
!Ci I ru I I uo '" Ir tr I 1 I G R R C P R Y M E C K R 0 A 0 C L A 0 C V r. L Q JI G I C G 
(Br7oola dioical R G CPR I I.MR CK RDS D C LAG CV C Q KN · G Y C G 
CPI GHANPIC-NK-P-CKTHNNCSGAWFCQACWllSARTCGPYVG 
OT V H S 0 GT TRF G CT I 
Figure 4. Sequences of CMTI and CPI, and their homologues. 
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2.3 Enzyme Inhibitor Interactions 
Most of the information was found in the literature and it was 
supplemented with observations from the model structures. 
2.3.1 CPA/CPI 
Figure Sa illustrates the CPK wireframe model of the inhibitor/enzyme 
complex and the highly complementary surfaces of the two molecules 
can be seen. In the Ca wireframe model, the extended c-terminus of 
CPI can be seen t o be penetrating into the active site of CPA; Figure 
Sb. 
A summary of primary and secondary contacts is listed bellow: 
* The four C-terminus residues ·(P36 to G39) of CPI form the primary 
binding segment which inserts into the a c tive site of CPA (binding 
subsites(S3 , s 2 , s1 , s1 •). This segment is very flexible and becomes 
ordered upon binding. 
* A secondary contact region extends from residue W27 to 830. 
Hydrophobic interaction through amino ac i d side chains are involved 
in the strengthe ning of primary contacts . 
* Hydrogen bonding; 
Asp29c 
Ser30c 
Ile247a, side chain N to carbonyl 
Ser24 6a, hydroxyl to carbonyl 
(where c denotes CPI and a indicating CPA) 
As indicated, all the primary and seconda ry contact residues are 
located in the region 22 to 39 . 
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Fig. Sa. Dlustration of the tight binding of CPI (green) and CPA (yellow). 
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2.3.2 Trypsin/CMTI 
The tight binding between trypsin and CMTI can be seen in Figure 6a. 
Figure 6b shows the exposed binding l oop of the inhibitor in the 
active site of trypsin. Trypsin cleav es on the carboxy-terminal side 
of Arg or Lys residues which are larg e, positive and hydrophilic and 
can be accommodated in the binding p o cket and held in place by 
electrostatic interactions. The mecha nism of action of trypsin is 
characterised by the concerted attack on the carbonyl carbon of the 
peptide bond by Serl95 to yield an oxyanion tetrahedral intermediate 
stabilized in an "oxyanion hole" in which the negative charge on the 
carbonyl carbon is stabilized by hydrogen bonds to the enzyme. The 
primary binding loop of CMTI is Val2 to Meta. The hydrophobic side 
chains of this loop (Pro4, Ile6, Leu7, and Meta) make up, together 
with Val2, Tyr27, Leul7 and Alala, a curved hydrophobic surface. 
2.4 Model Structure Of The Hybrid Peptide 
The sequence was designed by first i solating, then joining together 
the appropriate N-terminus structure (residues Rl to Ll7) from the 
CMTI file with the C-terminal struct ure (residues G20 to G39) from 
the CPI file. The final hybrid structure was arrived at by docking 
the CPI substructure onto the CMTI backbone, then creating a peptide 
bond between Ll7 and G20. The hybrid peptide was then subjected to 
energy minimisation under the DREIDING force field. 
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Fig. 6a. Interaction of CMTI-I and trypsin in the crystal complex. 
Figure 6b. Wireframe Ca model of the same view as above. 
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Figure 7 depicts the back.bones of the hypothetical hybrid protein, 
CMTI and CPI. The hybrid closely resembles each of its "parents". In 
order t o see if che hybrid peptide could accommodate both trypsin and 
CPA without". any steric hindrance, it was displayed with it:s acc.ive 
sesments bound to the proteases as shown in Figure 8 and 9 . 
Fig. 7. The alignment of the backbones of CPI, CMTI and the hybrid 
peptide. 
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Figure 8. Accessibility of the active segments of the hybrid peptide to CPA and trypsin. Ca. 
model. 
Trypsin 
Carboxypeptda.se A 
Fig. 9. Model of a similar trimolecular comple:x. Hybrid in bold, CPA in dotted lines and 
trypsin in medium thick lin es. From reference 2. 
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2.4.1 The Hybrid Sequence 
GVCPMILMECKKDSDCIAECVCGPNGYCGPYV 
The sequence shown above was arrived at by modelling studies and by 
information from the literature. The rationale of the sequence is 
summarised below: 
G 
Rl was changed to glycine because i t extends into the active site of 
CPI. The side chain of Rl in CMTI is involved in a hydrogen/ion pair 
with G29, fixing the amino and carboxy termini to the core of the 
inhibitor structure [71). This carboxy terminus is no longer present. 
Homologous inhibitors show sequence variation at this position 
therefore the ionpair/hydrogen-bondi ng interaction is not crucial for 
activity or folding. 
GPN 
These residues were taken from the s equence of EETI-II, a squash 
family inhibitor. They have been imp licated as a nucleation site for 
folding in some proteins. 
PYV 
These amino acids constitute the CPI's active site, and it was fully 
preserved with the exception of G39 which was omitted. G39 is cleaved 
off by CPA but the inhibitor remains active. 
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M 
The R at position 5 (P1 ) of CMTI s equence was changed to M in order 
to create a multispecific inhibito r. Mcwherter et al. [77) 
investigated sequence variations o f CMTI-III and found that several 
substitutions at the P1 site altered the specificity of the inhibitor 
to inhibi t a t least three other proteinases (human leukocyte 
elastase, human leukocyte catheps i n G and chyrnotrypsin). 
Part 3 
Design And Synthesis Of A CMCPI2 Encoding Gene 
3.1 Design Of A Gene Coding For CMCPI2 
Gene design required the following considerations. The organism in 
which the gene would be expressed influenced the codon choice for 
each amino acid. The cloning vectors should be chosen and their 
characteristics studied. In this .p roject, two vectors are used; one 
for gene s ynthesis and the other f or gene expression. Vector choice 
governs the type of restriction s i tes that could be engineered in the 
gene for the purposes of excising the gene out of the synthesis host 
and subsequent subcloning it into an expression vector. 
At the ouset, gene design involved translating the known amino acid 
sequence of a peptide into a DNA sequence using preferred codons for 
the chos e n expression host, the main reason being that you want to 
produce protein in abundance from the gene. Accuracy of gene 
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transcriptio n is also assured when h ighly utilized codons are used . 
In single-cell organisms , Grosjean a nd Fiers [78] indicated a direct 
relationship between the level of e xpression of a gene and its codon 
bias. The genetic code comprises 60 codons which code for 20 amino 
acids, 3 stop codons and one start c odon. This means that most of the 
amino acids a re coded for by more than one codon (degenerate codons) 
In a given s pecies, characteristic g enes prefer certain codons . In 
this work, c odons used were as repor ted by Ken-nosuke Wada et al. 
[79] . 
While it is important to use preferr ed codons, it does not mean that 
the inclusion of low readthrough codons would lower the level of 
expression of a gene. Good expressio n of genes with a low number of 
preferred codons is possible . For e x ample, in E. coli the 
chloramphenicol acetyltransferase g enes has codons similar to that of 
poorly expressed genes. When expres s ed under a strong promoter, 
Robinson et al. [80] observed high l evels of expression . In fact , 
some natural genes possess rare codons which are thought to 
constitute pause sites that enable t he nascent polypeptide to fold 
properly. Proteins with more . than one disulphide bond tend to use 
pause sites as a means of allowing t he correct order of -SH pairing 
to form [81] . Note that it is also wise to use different codons for 
repeated amino acids so as not to e x haust a particular species of 
tRNA synthe thases during expression. 
The coding s trand of the gene is di s played in Figure 10 with the 
amino acids it codes for given below. A Smal and a HindIII site were 
included to allow excision of the g e ne from the synthesis vector. As 
j 
I 
II 
i 
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included to allow excision of the gene from the synthesis vector. As 
indicated in Figure 10, the gene cons i sts of 32 amino acid residues 
(99 bases) and terminates with a TAA s top codon. At the 5' and the 3' 
ends of the gene is a 15 base long sequence which would allow overlap 
between oligonucleotide and synthesis vector sequences. In total, an 
oligonucleotide sequence consisting o f 135 bases was designed . 
5'TCGAGCTCGGTACCC GGG GTG TGC CCG ATG ATA TTG ATG GAA TGT 
g v c p m i 1 m e c 
AAA AAA GAT AGT GAT TGC TTA GCG GAA TGT 
k k Cl s d c 1 a e c 
GTG TGT GGA CCG AAT GGT TAT TGT GGA CCT 
v c g p n g y c g p 
TAT GTG TAA AAGCTT GGGGATCCTCTAGAG 3' 
y v * Hi nd[[{ 
Fig. 10. Assignment of codons to the multispecific protease inhibitor gene. The sequence in 
bold (CCCGGG) is a Sma 1 restriction site,* - denotes a stop codon (TAA) and the 
underlined sequences arc the two 15 bases long arms. 
I. 
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The sequence coding for the 32 ami no acid peptide (CMCPI2) was then 
scanned f o r restriction sites usin g the GCG program database of 189 
restriction sites. This allows one to check if unwanted restriction 
sites have been introduced during the assignment of codons to the 
amino acids. Ideally, the restric t ion enzymes (Smal and HindIII) 
should n ot digest within the gene sequence. The folding o f the 
transcribe d RNA molecule was exami ned using MFOLD and PLOTFOLD from 
GCG; by changing codon usage for s pecific amino acids, the amount of 
energy r equi r ed to denature any s e lf complementary struct ure was 
minimised to a value of -7.6 Kcal / mol. This energy minimisation was 
done in c onjunction with the optimisation of codon usage, while at 
the same time it was seen to use d ifferent codons for repeated amino 
acids. 
3.2 Synthesis And Purification Of The 135 Mer 
Oligonucleotide 
The oligonuc leotide was synthesize d in one run as stipulated in 
section 5.3.6. During synthesis, not all reactions go to completion 
especially for sequences longer than 80 bases . As a result there are 
incomplete oligonucleotides mixed together with the complete product. 
Incompl e t e s equences do not c onta i n the S'DMTr group, as the group i s 
removed be f o re addition of each c onsecutive phosphoramidi te. Onl y n ew 
bases contain the S'DMTr, hence a n addition that does not go to 
completion lacks this group. 
The prese nce of the DMTr group was used to separate completed 
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oligonucleotides from aborted sequences. The HPLC ion-exchange resin 
binds all oligonucleotides, as they are negatively charged. As the 
concentration of cl-(LiCl) increases, shorter sequences are eluted 
first since they have fewer negative charges and longer sequences are 
eluted last. The DMTr group is uncharged, but three phenyl groups 
interact non-specifically with the resin via hydrophobic 
interactions, causing the oligonucleotide which has the DMTr group to 
elute late r than if it lacked the DMTr group. Consequently, there is 
always a gap between the elution of the longest incomplete 
oligonucleotide and the oligonucleo tide of interest. Figure 11 shows 
the elution of the 135 bases long o ligonucleotide and its incomplete 
sequences. 
The purification step was conducted for the purposes of estimating 
the concentration of full length s e quence using the HPLC 
chromatogram . In the following gene synthesis section, crude 
oligonucleotide preparations were used. Primers for PCR purposes and 
DNA sequencing were also used in a crude form because they were all 
less than 40 bases in length. 
~ r I 
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Retention Time [min] 
Figure 11. HPLC purification of the 135 bases long oligonucleotide. Peak 9 denotes 
oligonucleotidcs synthesized to com1>lction, which constituted about 10% of the synthesis. 
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3.3 Synthesis Of A CMCPI2 Encoding Gene 
The gene synthesis method described by Mandecki [82] was made use of. 
The method s tems from the observation that an oligonucelotide with a 
sequence derived from DNA sequences on the two sides of a DNA 
double-strand break (spanning the bre ak) can direct the repair o f t he 
break, Figure 12. The method is simple and affordable compa r ed tu PC R 
strategies o f gene synthesis. 
Oligonuclcotidc 
L.ineari zed 
Plasmid DNA 
5' 
CGG A rccccA GGGAA !TCAC 
5' 
CGGATCCCC GGGAA Tl CAC 
GCC!AGGGG t CCCJrAAGTG 
Cleavage Silo 
CGGATCCCC Ii GGGAA TTCAC 
Figure 12. Principles of the mutagcncsis method. Th e plasmid molecule is pWMJOO clca1·cd al ! ·1 c 
Sma 1 site. The oligonuclcotide directs repair of the gap after transformation into an C. coli ho .~t. 
As mentioned e arlier, the oligonucleo tide had arms of 15 bases at the 
5' and J' ends o f t he CMCPI2 gene . The arms p rov ide a n overlap 
between the o ligonucleotide and the DNA s e qu e nces of Smal line;u· iE;ed 
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synthesis vector, pWM528 . The cloning strategy is depicted in Figure 
13. The parent of this vector (pWM5 21) is the first totally synthetic 
plasmid of E. coli which was made through the FokI method (83] . The 
plasmid contains synthetic modules f or B-lactamase (bla) encoding 
gene, lacz gene fragment and an orig in of replication. Its 
multicloning site (MCS) is the same as that of pUC18. The bla gene 
allows selec tion for clones carrying the plasmid in medium containing 
a B-lactam antibiotic. And the lacz gene fragment expression results 
(if in an a-complementing strain of E. coli such as JM83) in blue 
colonies on solid medium containing 5-bromo-4-chloro-3-indolyl-B-D-
galactopyranoside (X-gal) . The cloni ng of a gene in the MCS disrupts 
expression of the lacz gene fragment and results in white host 
colonies. 
Two mechanisms have been proposed f o r the transfer of information 
from oligonucleotide to plasmid DNA in E. coli. First, it is 
envisioned that oligonucleotide spanning the break anneals to the 
strand of denatured plasmid which c r eates a substrate for the nick-
translation / gap-repair process. Exonucleolytic repair of plasmid DNA 
and filling of gap by DNA polymerase may occur (84]. Secondly, a 
break in a plasmid DNA strand may b e a signal for DNA polymerase 
which is in the process of replicat i ng plasmid DNA to switch template 
from the plasmid DNA strand to the o ligonucleotide. After passing the 
break, the DNA polymerase would swi t ch template again to continue 
replicating the plasmid DNA (85] . 
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ll5 m~r oligonucleotide 
s· 
L.....J Wl-lfl 
S,.• L 
Heat dcna.curc, allow to anneal 
Sfl'•l HLndIII 
n Trans f orm E.coli JMSJ DNA repair 
Figure 13. Schematic representation of the cloning procedure in the plasmid 
pWM528. 
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3.3.1 Screening OF Transformants 
JM83 cells transformed with the mix ture of the oligonucleotide and 
denatured plasmid were plated on LB solid medium supplemented with 
ampicillin and X-gal. Twenty seven transformants were obtained; 17 
blue and 10 white. The white clones were the ones suspected to be 
carrying the CMCPI2 gene. 
The white clones were ascertained f or the presence of insert through 
PCR screening as shown in Figure 14 . The primers used are shown in 
Figure 15. A sample of JM83 cells transformed with supercoil pWM528 
was also PCR screened. The product from this PCR serves as a negative 
control. If there is no insert in t he plasmid, a 126bp product is 
expected. With the desired insert t he product should be 23lbp. The 
authenticity of the cloned CMCPI2 gene was further assessed by 
sequencing. Two clones that were s e quenced using the pWM/pUC primers 
gave the expected gene sequence. Fr om now on, pWM528 carrying the 
CMCPI2 gene is designated pWM528: : CMCPI2. 
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Fig. 14. Non-denaturing polyacrylamide gel electrophoresis of PCR 
screening results. The product of the supercoil pWM528 control (lane I) runs lower than 
those samples which contain the insert (panels 2, 3, 4, 6,8) and PCR products of clones 
lacking insert (lanes 5, 7) have the same mo bility as the control. 
C 1~c z. l~o . . . 
. . . GGAA. TIG i GAGCC-GA T MCM ffiCACACAGGAAACAGCT A TGr:.C 
pUC/pw'M reve rse primer site 
pUC/pWM forHard pri mer site 
TATGA~ACG~~TTGCCGTCG:'TTACAGCG~CG ... 
SmaI 150 
Fi~111re 15. pWM521 (lacks MCS which is present in pWM528) sequence showing the 
positions of the fonrnrd and reverse primers used in PCR scn:ening. 
3.4 Construction Of pMAL-M2 (the pMAL-pk/CMCPI2 Fusion) 
pfv'IJ\L-pk is a c: ·:_· i ·1a. tive o f pM.1'.L-p, and c ontain s an ente r okinase 
cleavage sequ~;i;e e ngineered in i ts MCS downstream of the facto r xa 
p WM 528 : : CMCP I. : 1. 1:; Smal / HindIII dL'..)• ; :;Lcu L u • .; .;: c _i_ :_; ,. t lie.! 'l"li• · 
elec trophores i . , F i gure 16, the gene DNA (105 bp) in lane 2 is 
c o 111i.91«1t • .i.11 ~ 1 w ; · l• 111 . 11 !·:· · 1 1 > ~ -1;\ , ,j 1 10 l i p i 11 I.it! <' 
122 _ 
110 -
1 2 
Fig. 16. Re:rn lt:i of the isolation of CMC P12 gene from a mixtun~ of II ind Ill I 
Sma l di ~'. l'S ll'd pWM52S::CMCPI2 hy 11011-denaturing polyanylami<k gel 
elect ro1il 11l1·t·sis. 
The g e ne was t 11 ,_; !1 r e covered from the gel by e l ectro elution . Tl! .::! 
conc e ntrat i on ' the CMCPI2 DNA was quan tified and then li a ted t o 
the pMAL-pk v •~< L -:i r which had been trea t ed as indic t e d in Fig ur e 17 . 
In bri e f , pMAL p k was digest e d with Ec o Rl followed by treatme nt wi t h 
nuclease Pl wh ich removes the overhangs created by EcoRl. Nucl eas e Pl 
has a single - s :_c3nd-specifi c endonuclease activ ity (double strande d 
substrates r ·· !l/d1· o lyz e d v e ry ::; l o wly) and .::i J 'nuc .L1.; ot_i.d.:i::; 1:! .1c t· i. v i. L ·_.: 
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[86] . As a result, the blunt ending step was done for a limited time 
of 25 minutes which had been determined as appropriate. To terminate 
the activity of nuclease Pl, the r e action mixture was extracted with 
phenol/chloroform. DNA obtained at this stage was digested with Hind 
III. The end result is pMAL-pk wi th a blunt and a sticky end into 
which the exc i s ed CMCPI2 gene was ligated. 
lacZa 
"- rrnB 
\ \ 11irm1n a1 o r 
pMAL-pk ~ Amp' 
~i 
---- polyl i n ~ er -·----
· ·'AalE .. / _ ::.~~,,@JEcoH iT :~.~.J Hi~ ... lac.:: .. . 
~ £::oK I : 1o ~ st 
Y Nuc 1 e~s ~ P 1 :r~::: 
I hinclll 
r 
.. ~01E .. !' :: - c:=::: ... lccZ ... . 
.=xo EK 
-
D ligate 
Figure 17. Construction of the plasmid pMAL-pk: :CMCPI2. 
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3.5 Expression From pMAL Vector s 
The pMAL expression vectors are suppl ied by New England Biolabs, and 
provide a simple system for expressio n of genes and purification of 
the resultan t p roteins; Figure 18a. Figure 18b shows a schemat i c 
drawing of pMAL-p; its polylinker reg ion and that of pMAL - pk are 
indicated. These vectors supply the ma1E (which codes for 'maltose 
binding protein' or MBP) fused throug h a polylinker region to the 
lacza gene. Transcription of the fus i on complex is controlled by the 
• 
tac promote r , a nd strong rrnB ribosomal RNA transcription terminators 
have been cloned downstream of the 1a cza gene to prevent 
transcription from ptac from interfer ing with plasmid functions. The 
promoter is kept in a switched off o r repressed state by lac 
repressor, the product of the lacI g ene, which is also carried by the 
pMAL vectors. Cloning of a sequence (containing a stop codon) into 
the polylinker and derepression of t h e promoter by isopropy l-P-D -
thiogalactos ide (IPTG) interrupts the ma1E-1acza fusion. This changes 
colony colour from blue to white in a n a-complementing E. coli host 
(TB1) . Furthermore, cloning in this region gives rise to a protein 
fusion consisting of MBP and the target protein. To separate the two 
domains, a s e quence coding for the cleavage site of enterokinase is 
provided in the v ector pMAL-pk. The vectors also contain the entire 
signal seque n c e of the ma1E gene which directs expression of fusion 
proteins into the periplasm of E. c oli thus facilitating extraction 
of the fusi o n protein. In addition, the periplasm offers a much more 
I 
oxidative environment which is condu cive to disuphfide bond I 
I, 
L 
I•' 
•  
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formation. The formation of a fusion protein may aid in protection of 
the mRNA and prevent digestion of the protein by proteases. 
~kJtcse br.dng prot81~an protein o f interest 
)... ~ _/' -~~-'< 
~ · SK cleavage site 
N'eitoSB tircing ste 
- -
-
---
8utioo with free ~osa 
-~ 
-~ 
- -~ 
-~ 
- -~ 
I 
Bi rd ng to amyl ose resin Ceav~with 
I 
!\ 
i\ 
I\ 
'1 ! \ 
~ 
~ 
~-
--._; 
~ 
!\ separation by 
I\ reverse phase HPLC 
! \ 
~ 
~ 
~ 
enterokinase 
t 
~~ 
~~ 
~~ 
Fig. 18a. Purification scheme of MBP-CMCPI2 fusion protein and its 
enterokinase digests fragments. 
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'\. rrnB 
\ \ tarm1nator 
Jae I 
Polylinker: FaC1orXa rS•c 11 rKpn 11 r£•g ll rBwrH1j rStu 11 cleavage 
m:J!E.. . TCG AGC [CG GT A CCC GGC: CGG GGA TCC ATC GAG GGT AGG CCT sit') 
lie Glu Gly Arg ~
f EcoRll ra.. .. m-1rXba /l rS•/ /1 rPst 1-, rHlnd /Ill 
GAA nc AGT MA ACC CTC GA T GGA TCC TCT AGA GTC GAC CTG CAG GCA 'AGC TIG .... /.JCZll 
pMAL-pk polylinker: 
ma/£ .... .. .. lleGluGlyArgSerGly AspAspAspAsp Lys ................ LacZ a 
tXa EK 
Fig.18b. Plasmid map of pMAL-p and its polylinker region. The polylinker 
region of its derivative pMAL-pk is also shown. 
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3.5.1 Expression Of MBP-CMCPI 2 Fusion Protein 
The plasmid pMAL-M2 was introduced into E.coli strain TBl. PCR 
screening was again used to determine whether the gene, CMCPI2 was 
present in MCS of the vector. The correct frame of the gene was 
assessed by sequencing two clones which were positive by PCR 
screening. The final result was to choose a suitable transformant, 
TBl(pMAL-M2) to be used in fusion protein production. 
Expression was induced by the addition of IPTG to mid log phase of 
the culture and incubation further to allow the fusion protein to 
accumulate . Samples taken before induction and one to two hours 
thereafter, were run with suitable controls on 14% SDS polyacrylamide 
gel - see Figure 19. Before induc t ion, there appears to be no fusion 
protein accumulation (lane 2) . Thi s shows that there is no fusion 
protein synthesis from pMAL-M2 in TBl before induction and that the 
repressor protein coded for by pMAL-M2 prevents detectable levels of 
expression from the tac promoter . However, one and two hrs post 
induction a thick band of slightly greater Mr than the 45 kDa marker 
protein band appears (lane 1) . Pure MBP has a molecular mass of 42 
kDa [87] . Since CMCPI2 peptide has a calculated molecular mass of 
3498.14 Da as estimated by GCG; its fusion with MBP should give a 
protein of about 45 kDa. Hence it was concluded that the thick band 
represented expression of the cloned inhibitor gene fused to the MBP 
gene. 
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1 2 3 4 5 6 
Fig. 19. Expression and purification of MBP-CMCPI2 fusion protein. 
Lane I) Prot ein molecular weight markers 
2) TB l (pMAL-pk) uninduced 
J) TB l (pMAL-pk) 1 hr post induc tion 
-1 ) Tl3l (pMAL-pk) 2 hrs after induction 
5) TB t(pMA.L-pk) periplasmic extract 
6) Amylose resin purified MBP-CMCPI2 
I ,, 
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3.5.2 Purification Of MBP-CMCPI2 Fusion Protein 
A one litre log phase culture of TBl(pMAL-M2) was induced and 
periplasmic proteins were extracted by cold osmotic shock. The 
periplasmic p reparation was then loa ded on a column of cro ss - linked 
amylase. MBP has been shown to bind oligosaccharides with hig h 
affinity [88 ] . The interactions invo lve mostly hydrogen bonds between 
the oligosacc haride hydroxyls and charged side chains in the MBP 
binding groove. Van der Waal's interactions further strengthen the 
affinity of MBP for oligosaccharides . The result is that only the 
MBP-CMCPI 2 fusion protein binds to the amylase resin. This is then 
eluted with 10 mM maltose. The maltose acts as a competitor for 
binding on t h e fusion protein . As can be seen in Figure 19, lane 6, 
only the MBP-CMCPI2 fusion protein band is visible . Lane 5, indicates 
that perip lasmic expression facil i tates protein purification because 
there are fewer protein in that compartment . Through the use of the 
• 
affinity co lumn , high y i elds of pur e fusion protein were obtained i n 
one purific ation attempt. The fusi on protein at this stage is in 10 
mM maltose which was remov ed by dia lysis. Since the affinity of 
maltose f or t he MBP groove is high, fractions containing the fusion 
protein were diluted ten times in c olumn buffer before dialysis 
against 1 0 litres of 10 mM Tris (pH 8.0), 100 mM NaCl with 4 changes 
over 24 hrs at 4°c . To remove salt , the fusion protein fraction was 
dialyzed exhaustively against dist i lled water , and later concentrated 
by freeze drying. 
Separation o f CMCPI2 from its fusi on partner was achie ved through the 
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use of enterokinase (enteropeptida se; E.C . 3 . 4.21.4) which is a 
serine protease that recognises the amino acid sequence NH2 - Asp-Asp-
Asp-Asp-Ly s-"'1-x. The hydrophilicity of this sequence is likely to 
aid in the adoption of a highly e xposed conformation in the three 
dimensional folding of a protein . Hence in the fusion construct it 
would be located at the surface, f acilitating processing by 
enterokinase. The natural substrat e of enterokinase is trypsinogen 
which it cleaves at the C-terminus to release active trypsin (89) 
The aspar tic acid residues in the recognition sequence can be 
substituted by glutamic acid (90) . Cleavage of MBP-CMCPI2 fusion 
protein was carried out for 1, 3, 6, 12, and 24 hrs as depicted in 
Figure 20. After 6 hrs of digestio n (lane 5), two digestion products 
can be seen. This indicates that t he protein is being cleaved at two 
sites. Presumably, one of the site is that of enterokinase. Attempts 
to enhanc e cleavage site accessibi lity by denaturing the fusion 
protein with 6M guanidine hydrochl oride prior to digestion were not 
successful. The enterokinase diges t of the fusion protein was 
separated through the use of rever se phase HPLC . Proteins bind on the 
resin via hydrophobic interactions and are eluted in the order of 
increasing hydrophobicity using a gradient of acetonitrile. Figure 21 
shows the results of the separation; three major peptide peaks were 
resolved, no. 1: CMCPI2 processed at a wrong site, no . 2: CMCPI2 
cleaved a t the enterokinase site and no . 3: MBP . The assignment of 
peaks (1 and 2) to peptides was done through N-terminus sequencing. 
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KDa ~~~-~~--~-
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36 
29 
1 2 3 4 5 6 7 
Figure 20. Cleavage of MBP-CMCPl2 fusion protein. 
I 
Lane 1) Calibration proteins 
2) Uncut fusion protein 
Lanes 3, 4, 5, 6, 7: incubation of the fusion protein with enzyme for 1, 3, .. 
6, 12 and 24 hr(s) respectively 
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Fig. 21. Reverse phase separation of a n enterokinase digest of MBP-CMCPl2 
fusion protein. Column, TSK-GEL ODS-SOT m (15cm x 4.6mm ID, 5µ.m); elution 
solution A (0.1 % TFA in water), buffer B ( 0.085% TFA in 80% acetonitrile); 
sample, lmg digest in lml buffer A ; elution- 60 min linear gradient from 10% to 
100% buffer B; flow rate , 0. 7ml/min. 
Peak 1) Truncated CMCPI2 
2) Properly processed CMCPI2 
3) MBP 
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3.5.3 Characterisation Of Peptides Generated By 
Enterokinase Cleavage 
To ensure that Enterokinase cleavage had produced the required N-
terminus o f peak 1 and peak 2 peptides, a sample of each was 
partially s equenced to determine the first few residues of the N-
terminus. The results are presented in Table la and lb. The 
processing of each peptide by enterokinase is schematically shown at 
the bottom of table 1 . It is evident that the truncated CMCPI2 was 
cleaved at the factor Xa site . Initially, it was suspected that the 
enterokinase enzyme was contaminated; an assessment of the 
preparatio n by reverse phase HPLC gave one peak, indicating high 
purity. The supplier of enterokinase was also changed and the pattern 
of digestion as assessed by SDS polyacrylamide gel electrophoresis 
and reverse phase HPLC were identical to the ones mentioned above. 
Light et al . [90] investigated limited digestion of protein 
substrates containing sequences of one or more acidic residues 
preceding a basic residue (R, K) ; he found that bovine serum albumin 
was in fa c t capable of digestion at these sites as a s-carboxymethyl 
derivative . In this study, the Gly preceding the Arg in factor Xa 
recognition sequence lacks side chains which could shield the Glu 
preceding it . As a result cleavage could take place. 
., 
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A) 
.. 
::: ·> . Cycle PTH Amino Acid Yield (pmoles) 
1 s 166 
2 G 1 060 
3 D 424 
4 D 531 
5 D 5 72 
6 D 532 
7 K 132 
8 G 2 13 
9 v 193 
10 (C) -
11 p 37 
1 2 M 72 
13 I 27 
B) 
.. 
Cycle 
. 
PTH amino a cid · Yield. (pmoles) 
1 G 204 
2 v 121 
3 (C) -
4 p 10 
5 M 11 
· Table 1) Result s of automatic sequencing of the products of 
enterokinase digestion of MBPCMCPI2 f u sion protein. The amino acid residues 
that pro duced largest proportions and their yields are reported. 
A) N-terminal sequence of peak 1 pepti d e (truncated CMCPI2). 
B) N-terminal sequence of peak 2 peptid e (properly processed CMCPI2) 
To understand the varying yields of the PTH-amino acids shown in 
table 1 a and 1 b , it is necessary to describe briefly the stepwise 
degradation of proteins by the method of Edman which was used in this 
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sequencing reaction. To prepare the N-terminal amino acid for removal 
from the protein, phenyl-iso- thio -cyanate (PITC)is coupled to its a 
-amino group to produce a phenyl- t hio-carbamyl-peptide (PTC-peptide) 
The PTC peptide bond is cleaved by causing the N-terminal PTC-amino 
acid to cyclize under acid condit i ons producing an anilino-
thiazolinone (ATZ) derivative of t he amino acid. The ATZ-amino acids 
are unstable and are converted to PTH-amino acids usually by heating 
to 80°c . It is at this stage of t h e conversion of ATZ-amino acids to 
PTH-amino acids where much of the problem arises; some PTH-amino 
acids tend to decompose during the conversion and decrease the yield 
of those amino acids. 
As indicated by the N-terminus sequencing results, peak no. 2 
fraction contained properly proces sed CMCPI2 peptide. Further 
attempts to ascertain authenticity of the peptide involved analyzing 
the composition of its amino acids . The results are displayed in 
Table 2. At this stage, it is evident that the inhibitor peptide has 
been expressed in E. coli although in minute quantities {10 to 40 µg 
per fusi on protein isolated from a litre of TBl(pMAL-M2) culture} . 
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Table 2) Amino acid composition of CMCPI2 inhibitor in mol/mol 
3.7 (4) 
v 2.8 (3) 
c (6) 
p (3) 
M 1. 9 (2) 
E 2 .2 (2 ) 
K 1.5 (2) 
D/ N 3.2 (2) 
s 1.1 (1) 
L 1 .9 (2) 
I 0.9 (1) 
y 1. 8 (2) 
A 1.2 (1) 
Notation : - not determined and (), theoretical values 
3.5.4 Discussion 
The pMAL expression vector chosen for t h is work has proven to be a 
very good producer of MBP-CMCPI2 fusion protein ( yields as high as 
21.31 mg per litre of E . Coli culture were obtained), which was 
translocated to the periplasm of E. col i. The idea here was that on 
export to the periplasm the protein woul d be able to fol d to form 
correct disulphide bridges . The MBP fus i on partner lacks any cysteine 
residues which could interfere with disulphide bond formation within 
the target protein. The fusion protein was purified by affinity 
chromatography to homogeneity as assesse d by SDS-polyacrylamide gel 
electrophoresi s . However , processing of the fusion peptide by 
enterokinase at the factor Xa cleavage s ite (NH2 -Ile-Glu- Gl y-Arg- '1t -) 
was unexpected and resulted in low yields of the peptide of interest . 
Only about hal f of the fusion protein was correctly processed in 
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analytical scale digests. Preparative scale digests with the serine 
proteinase, enterokinase, were not very successful and could be due 
to inhibition of the enzyme by the inhibitor, CMCPI2. These drawbacks 
coupled with high costs of the cross-linked amylase resin and 
enterokinase discouraged further attempts to produce CMCPI2 inhibitor 
using the pMAL expression system. Nonetheless, correctly processed 
CMCPI2 was obtained as indicated by the N-terminus sequencing result 
(NH2-Gly-Val-Cys*-Pro-Met; *- not determined) . It was then decided to 
express CMCPI2 in the yeast, Pichia pastoris. The cloning strategy, 
expression and purification of the inhibitor peptide is described in 
the next section. 
Part 4 
Cloning and Expression of A CMCPI2 Encoding Gene In 
Pichia pastoris 
4.1 Introduction 
Pichia pa s toris is one of the methylotrophic yeasts which includes 
Torulopsis, Candida and Hansenula. These organisms are all capable of 
using methanol as a sole carbon source. The initial step in the 
metabolism of methanol involves its conversion to formaldehyde which 
makes use of the enzyme alcohol oxidase I (AOXI) [91) . The synthesis 
of AOXI is regulated at the level of transcription by a promoter 
which is induced by methanol. It was this discovery which led to the 
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investigation of P. pastoris as a vehicle for the synthesis of 
heterologous proteins. Early success es in the production of 
recombinant proteins were achieved u sing the bacterium Escherichia 
coli as a host. However, the E . col i host is not capable of 
expressing authentic complex recombi nant proteins such as those of 
mammalian origin and hence it was n e cessary to investigate other host 
systems. The first yeast to be inves tigated was the well-studied 
baker's yeast Saccharomyces cerevisi ae. As unicellular eukaryotes, 
the yeasts are capable of accurate post-translational processing and 
modification of many mammalian prote ins. In general, the yields of 
foreign proteins produced in baker' s yeast have been low because of 
poor plasmid stability during produc tion runs [92] . This resulted in 
expression systems which may be difficult to scale-up to production 
volumes. The second factor contributing to low yields is that many S . 
cerevisiae secreted proteins are not found free in the culture 
medium, but are retained in the pe r iplasmic space in a cell 
associated form [93] . This can lead to tedious purification schemes 
and lower yields of heterologous p r oteins. Obviously, there was a 
need to look at alternative yeast hosts for stable high-level 
production of appropriately modifie d recombinant proteins. P. 
pastoris i s one of the hosts which was originally developed for 
industrial processes in the 1970s a s a source of single-cell protein . 
As a host for the production of rec ombinant proteins, P. pastoris has 
the subcellular machinery for performing post-translational protein 
modifications of eukaryotes. Secretory proteins are synthesized on 
ribosomes which are tightly bound to the rough endoplasmic reticulum 
(ER) and then translocated into t h e lumen of the rough ER, where the 
~ l 
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signal sequence is cleaved . This i s an important feature of any 
secretory system. Cleavage is carr ied out by a signal peptidase at a 
specific recognition site. A dibas i c endopeptidase analogous to Kex2 
of S. serevisiae is implicated in cleaving secretory proteins at the 
recognition sequence -Lys--.lt-Arg or Arg--.lt - Arg (94) . The processing 
takes place in the Golgi complex where the endopeptidase i s located . 
Disulfide bond formation is a pos t -translational modification which 
occurs within the rough ER . Native disulfide bond formation is an 
integral a spect of the protein fo l ding pathway, and may play a part 
in protein assembly . In yeast, the enzyme protein disulfide isomerase 
(PDI) enhances isomerisation, redu ction and formation of disulfide 
bonds (95) . This takes place in t h e lumen of the rough ER where the 
redox state is more oxidizing than that of the cytosol [96] . PDI i s a 
homodimer and each of the monomers has two active sites characterised 
by the sequence -CGHC-, which is similar to that of prokaryotic / 
eukaryot ic thioredoxin. It is proposed that the most N-terminus 
cysteine prov ides the essential reactive thiol group . The mechanism 
of action of PDI is not fully understood but it is thought that it 
facilitat e s protein folding so t hat the cysteines to be linked are 
brought in close proximity to eac h other. 
The addition of a limited number of high-mannose oligosaccharides to 
specific Asp residues is also car ried out in the rough ER. P. 
pastoris h a s the advantage of not being capable of hyper-
glycosylation as compared to S . c erevisiae which can add a -1-3 glucan 
linked oligosaccharides that conf er hyper-antigenicity to the foreign 
protein; s uch proteins are unsui t able for therapeutic use. 
Glycosylation is a very important process for some proteins as many 
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• studies hav e shown that abnormal or inefficient glycosylation of 
• proteins leads to their misfolding and concomitant retention in the 
ER [97) . 
The use of P . pastoris expression vectors especially those which 
secrete proteins into the media simplifies protein purification and 
makes use of inexpensive media comp onents. The observation that few 
proteins are secreted by the organi sm constitute a first step in 
purification; secreted foreign prot eins usually comprise a large 
fraction of proteins in the medium. The inducer, methanol of foreign 
protein expression is inexpensive compared to IPTG used in most E. 
coli expression vectors. 
High cell - count fermentations are possible with P. pastoris secreting 
expression s trains. This leads to higher yields of foreign proteins 
but also results in accumulation o f protein degrading proteases . The 
degradation of secreted heterologous proteins by native proteases can 
be prevented in many ways. P. pastoris expressing strains are capable 
of growing across a relatively broad range of pH 3 . 0 to 7 . 0. This 
allows one to adjust the pH to a value where protein degradation by 
native proteases is limited. Amin o-acid rich supplements can be added 
to the medium to reduce protein d egradation by acting as excess 
substrates of the enzymes. The u s e of host strains lacking a gene 
(PEP4) which encodes a vacuolar p rotease that is responsible for 
proteolyti c activation of other v acuolar proteases has proven useful 
[98] . 
Very good yields are possible with P. pastoris expression systems. 
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For example, the secretory product of the gene encoding tick 
anticoagulant peptide accumulated in the medium to about 1.7 g/L 
[99]. The same gene has been expressed in S. cerevisiae but product 
accumulate d to levels which were about seven times less. Because of 
variations among experimental designs, it is difficult to make direct 
comparisons between the productivities of the two. Nonetheless, it 
serves a s a good qualitative comparison. In the above example, only 
one copy of the gene was integrated into the genome of P. pastoris; 
other repo rts indicate a direct c o rrelation between gene copy number 
and protein levels [100] . 
Compared to foreign protein produc tion in E. coli, P . pastoris 
expression protocols are very long and require good planning. 
However, the genetic manipulations are similar and the medium used in 
both cases is inexpensive since i t is a mixture of salts, trace 
elements a nd carbon source. P. pa s toris expression systems are fairly 
easy to u se c ompared to mammalian tissue culture and the bacul ovirus 
system. 
4.2 Design And Synthesis Of CMCPI2 Inhibitor Gene 
Codons assigned to the amino acids of the protein inhibitor gene were 
the same as in the design for expr ession in E. coli. It would have 
been ideal to make use of preferre d P. pastoris codons, but few genes 
have been isolated and fully sequenced from this organism . S. 
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cerevisiae is the only yeast whose genes have been well characterised 
in sequence. A summary of codon usage in S. cerevisiae and E. coli is 
tabulated by Ken-nosuke Wada et al. [79); it is apparent that codon 
usage between the two organisms is similar. It has also been 
demonstrated that P. pastoris and S. cerevisiae show a lot of genetic 
cross functi onality. For example, P . pastoris HIS4 gene functionall y 
complements S . cerevisiae his4 mutant s and the S. cerevisae HIS4 gene 
functionall y c omplements P. pastoris his4 mutants; other cross 
complementing genes that have been i dentified include LEU2, ARG4, and 
URA3. In addition, some E. coli genes have been produced in both 
yeasts in a biologically active form ; Tschopp et al . [101) expressed 
E. coli B-ga l a ctosidase in both organ isms. As a result , one is 
tempted to conclude that the inhibito r gene which was designed for 
expression in E. coli would also be e xpressed in P. pastoris. 
However, it is not claimed that the g ene would be expressed optimally 
and with pre dicted authenticity . 
The only change which was made in the CMCPI2 pept i de was at position 
1 where G was s ubstituted with R for the reason of allowing 
processing a t the K-'1t-R site during expression. The changes in the 
gene sequence which is carried by p WM528 were to be made through the 
use of PCR primers incorporating necessary mismatches as depicted in 
Figure 22. For the purposes of gene subcloning into the expression 
E.coli-P. p as toris shuttle vector, pHIL-81, a Sma 1 site was 
introduced a t the 5' end while a Xho 1 site was engineered at the 
3'end . The p roposed piece of DNA was then checked for the presence of 
unwanted res t r iction sites; Bgl II, Sma 1 and Xho 1 should not cut 
within the gene. 
., 
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Xho 1 
5' ff CT CGA GT] TGC CCG ATG ATA TTG A 3' J · · I • 11 
S'TCGAGCTCGGTACC GGG GTG TGC CCG ATG ATA TTG ATG GAA TGT 
g v c p m i 1 m e c 
AAA AAA GAT AGT GAT TGC TTA GCG GAA TGT 
k k d s d c 1 a e c 
GTG TGT GGA CCG AAT GGT TAT TGT GGA CCT 
v c g p n g y c g p 
TAT GTG TAA AAGCTT GGGGATCCTCTAGAG 3' I~\ \v Hindi ii 
3' ATA CAC ATT TTC GAACCCGGGAT 5' 
Smal 
Figure 22. PCR primers indicating the mismatc~es (*) which would allow site 
specific mutation of the CM CPU gene into a variant which starts with R 
thus allowing creation of an Xho l restriction site. 
64 
PCR amplification was conducted i n a mixture consisting of a Pst 1 
lineari sed pWM 528 : :CMCPI2 which f acilitated annealing of primer to 
the line ar templat e compared to a c ircula r template. Thereafter, the 
PCR product was loaded on a 12% nondenaturing polyacrylamide gel in 
order t o asses s its size - see Fi gure 23. The observed bands in lanes 
2 to 6 comigrated with the 120bp marker DNA in lanes 1 a nd 7. From 
the known nuc l eotide sequence, the PCR product is 117bp long. Since 
the obtained band has a molecula r mass which is c lose to the expec t ed 
one , it was concluded that the bands comprise the insert. To prepare 
the ampl if ied DNA for the n ext s t ep, i t was t reated with 
phe nol/ chlorofor m, digested with Srna 1 / Xho 1 , and named CMCPI2 · . 
Fig 23. Results of PCR amplification ofCMCPI2• from the plasmid 
pWM528::CMCPI2. 
Lanes 1,7) Calibration DNA 
Lanes 2-6) PCR product at increasing concentration 
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4.3 Construction Of pHIL-Sl::CMCPI2* 
As mentione d, the plasmid pHIL-Sl i s an E. coli-P. pastoris shuttle 
vector with sequences designed for s election in both hos t . Figure 24 
shows a t ypica l map of the plasmid. The left half of the plasmid is a 
portion of pBR322; there is an ampi c illin resistance gene (AMPr) and 
the f 1 -bacteriophage origin of replication (f1 ori). The EcoRl site 
present in this segment in the paren t plasmid has been eliminated. 
Note that al l these elements enable one to generate and propagate the 
vector in any E. coli strai n which is recombination deficient (recA-) 
and carries a se lectable F' episome such as TOPlOF' . 
Sal I 
pHIL-51 
8.2kb 
Bgl II 
• If the Xho 1 site is used tor cloning, the signal cleavage site (GCT CGA) must be 
recreated in order for the cleavage of the fusion protein to occur. This can be 
acheived by regenerating the Xho I site . 
Figure 24. A map of the plasmid pHIL-Sl. 
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DNA elements comprising the rest of t he plasmid are derived from the 
g~no~e of P. pastoris, except for the short regions of pBR322, used 
to link the yeast elements. The 5' AOXl and the 3' AOXl have DNA 
e~ements from the gene encoding the e nzyme alcohol oxidase and 
together aid in site directed integra tion into the genome of a host 
strain such as GS115. The P. pastori s HIS4 gene makes complementation 
possible in the defective his4 gene i n the host GS115 which can then 
grow in medium lacking the amino acid histidine. The gene PHOl codes 
for acid phosphatase and provides a s ecretion signal sequence which 
targets protein expression into the medium, and it helps initiates 
translation of genes cloned downstrea m by its ATG start codon. 
the construction of pHIL-Sl: :CMCPI2* involved ligation of 
Sma 1 I Xho 1 digested pHIL-Sl and CMCPI2* DNA. The end result is the 
recreation of the Xho 1 site at the f usion junction of the gene and 
the PHOl signal sequence. The recreat ed Xho 1 site acts as Kex2 like 
protease cleavage sequence that woul d enable processing of the 
recombinant protein during expression . In order to propagate and 
screen for recombinant clones, the l i gated mixture was transformed 
into CaC1 2 competency induced T0P10F' E. coli cells. Clones carrying 
pHIL-Sl: :CMCPI2* were screened f o r the insert by PCR screening 
and the results are displayed in Figu re 25. 21 clones were screened; 
10 were identified positive (lanes 3, 7, a, 9, 10, 11, 15, 19, 20 and 
21) , 9 had no inserts and 2 clones d i d not give rise to a PCR product 
(lane 22 and 12). The control PC~ product (lane 2) has a calculated 
length of 123bp and clones whose PCR products comigrated with it were 
. ' •;.i'(l ' l, · 
deemed negative . Any clones which had an insert produced PCR products 
of high mobility and theory tells us that it should be 233bp long. 
I 
I 
.. 
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The difference in mobility of PCR p r oducts of the control and 
positive clones accounts for the pre sence of the expected DNA 
fragment. Two clones which were pos i tive as per PCR screening were 
sequenced and the orientation of the sequence was determined to be in 
the right order. 
I. 
. 19181716 2~ a>\ 4131211)° . ~ ,\ tlJ / 0 987654321 
-------- ~ ---- - ------- -
' bp 
-
-
.. 
-
= -242 
- . i? 
..... 
·--
~-=- -122 = ·• 
M M 
· Figure 25. Non-denaturing polyacrylamide gel electrophoresis of PCR screening 
results. 
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4.4 Expression Of The Inhibitor Gene CMCPI2* In P. 
pastor is 
The use of P. pastoris expression v ectors stems from the discovery 
that methano l-regulated promoters, such as that controlling the 
alcohol oxidase I gene, are highly expressed and tightly regulated. 
In glucose o r glycerol-grown cells, alcohol oxidase is absent but 
constitutes as much as 30% in of the total protein in methanol-grown 
cells (104) . Therefore it was postulated that a foreign gene 
regulated b y the AOXl promoter would be e xpressed at high level, even 
in cells tha t contained only a single copy of the AOXl promoter - gene 
construct (expression cassette) . The expression cassette is inserted 
into the hos t g e nome, t hereby a void i ng potent i a l p lasmi d i n stabi l ity 
problems which are common in S . cerevisiae expression systems. The 
host harbour ing the e xpression cassette is first grown on repressing 
carbon sour c e s, such as glucose or glycerol, an unlimited mass of 
cells is g e n e rated without significant selection for mutants 
defective in foreign protein production . The cells are allowed to 
deplete the repressing carbon source and upon methanol addition, the 
expression cassette is switched on. A number of v ectors for 
intracellular or secretion e xpression are supplied by Invitrogen 
Corporation. 
The construc tion of GS115 strain carrying the desired expression-
cassette involv ed digestion of pHIL-Sl : : CMCPI2* with Bglll. After 
digestion, two plasmid fragments are generated. One carries the 
expected e xpression cassette flanked by portions of the AOXl gene. 10 
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µg of the diges ted DNA was transformed into GSllS cells which had 
been made competent by treatment with CsCl as laid down by the kit 
supplier. The strain GSllS is a histid ine requiring auxotroph meaning 
that it is d e fective in histidinol dehydrogenase (his4); only the 
transformed e xpression cassette has t h e HIS4 gene which then 
complements GS llS. Once the transformi ng DNA is in the cell, it 
integrates i nto genomic DNA according to the dictates of the AOXl 
sequences. Af t e r the homologous recomb ination event has taken place, 
the entire AOXl in GSllS is displaced by the expression cassette. 
GSllS recombinants have a slow growth phenotype on medium containing 
methanol compared to the wild type st r ain. The reason being that they 
no longer produce alcohol oxidase I, the product of the AOXl gene and 
they depend on the poorly expressed AOX2 gene for the utilisation of 
methanol. Screening for AOXl-disrupted transformants was done on MM 
plates, which are supplemented with methanol. A suitable control, 
GSllS (HIS4+ , Mut+ , albumin secreted) was also plated; Mut+ - capable 
of using metha nol. 53 transformants were obtained; ten were found 
positive i.e., HIS4+ and Mut-. 
To further p rove the presence of CMCPI2* gene in the genome of GS115, 
the recombinants were grown up for t h e isolation of their genomic 
DNA . Then the DNA was used in a PCR s creening protocol utilizing 
primers directed against the 3' AOXl and the 5' AOXl elements. In 
this way we were able to amplify a DNA piece which was loaded on a 
12% non-denaturing polyacrylamide gel. A control DNA PCR product 
obtained from wild type GS115 was al s o run in parallel. The results 
are shown in Figure 26. Lane 2 indica tes a DNA band corresponding to 
between 309bp and 242bp in length . I t is the PCR product of the 
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control. From the known sequence, the product should be 263bp long. 
Lane 4 shows a DNA band of just under 484bp; based on calculations, 
the experimental PCR product should be 353bp in size. The difference 
in size of the two bands is big enough to account for the presence of 
the expression cassette in GS115 genomic DNA. 
1 2 3 4 5 
Fig. 26. PCR screening of GS115 genomic DNA for the presence of the gene frab'ltlcnt 
CMCPI2°. 
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The next step was to establish the level of foreign protein 
production by the ten recombinant GS115 clones. 100 ml of BMGY 
(contains glycerol as a sole carbon source) medium was placed in 500 
ml baffled flasks and inoculated with a small amount of cells from a 
different clone on MD plates. The cultures were incubated at 3ooc 
with vigorous shaking for two days. During this step, the repressing 
carbon source glycerol is used up in the build-up of biomass. 
Thereafter, the cells were removed from the broth by centrifugation 
and resuspended in BMMY (supplemented with 0.5% methanol) medium and 
further incubated at 30°c. A time-course study after 1, 2 and 3 days 
post induction by removing only a portion of the supernatant for 
protein analysis by reverse phase HPLC was conducted. 20 µl of 
supernatant was made 50% in column equilibration buffer (0.1% TFA in 
water) and loaded on a c18 analytical column. Elution followed with a 
gradient of buffer B (0.085% TFA in 80% acetonitrile). Based on the 
chromatogram in Figure 21, the approximate retention time of the 
inhibitor peptide was known. Outcomes of the time-course study are 
shown in Figure 27a. A peak after 28 minutes (retention time) appears 
to increase in area during the expression phase. On the other hand, 
uninduced clones do not seem to be producing a detectable amount of a 
peptide with a retention time of 28 minutes. All the different 
recombinants assayed did not show a marked difference in the level of 
protein production as estimated by the area under the 28 minutes 
peak. The results should not be interpreted as if only one protein is 
secreted into the medium by P. pastoris strain GS115(CMCPI2*). In 
fact, at very high sensitive detector setting other proteins peaks 
corresponding to P. pastors secreted proteins were observed; 
especially after more than two days expression induction. At some 
s 
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Fig 2 7. Analysis of supernatants for the expression of the inhibitor peptide by reverse 
phase HPLC (A); purification of the inhibitor protein by an-ion exchange 
chromatography (B) ; peak 5 and 6 fractions (B) were then analyzed by reverse phase 
HPLC , only peak 6 was rich in the inhibitor peptide (C). 
I 
I 
I 
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instances, the 28 minutes peak star t ed declining in area probably due 
to peptide degradation by acid prote ase's. For this reason, large 
scale protein expressions were carri ed out for not more than two 
days. 
Supernatants derived from large scale protein productions were made 
to 0.06M Tris (pH 8.7), diluted by 5 0% in distilled water, filtered 
through a Whitman filter paper and t hen a 0.45~m acetate membrane 
before being p umped (5ml/min) on to a Super Q-6508 resin packed i n a 
stainless steel column (2.0 cm diame ter; 17.5cm length). The strong 
anion-exchange resin had been equilibrated in buffer A (0.06M 
Tris/HCl, pH 8 . 7) . At this pH, the inhibitor protein which has a 
calculated i s oelectric point of 4 . 62 should be negatively charged and 
therefore bind on the resin. The column was then developed with a 
step gradient of O. SM NaCl; c1- competes with proteins for binding 
sites on the resin resulting in elution. A number of peak fractions 
were collec ted but only the last one indicated to be rich in the 28 
minutes peptide - see Figure 27b. To remove salt, the pooled 
fractions we re dialyzed against 50mM Tris (pH 8.0) using dialysis 
tubing with a pore size cut-off of 2.00kDa. To concentrate the 
protein, the fractions were freeze dried. The material at this stage 
was not very pure because of the usage of a large column. Coloured 
impurities from the fermentation broth imparted a beige colour to the 
material. I t wa s then essential to further purify the protein using 
the c18 column mentioned earlier. A protein yield of 2.5 mg 
(estimated by Bio-Rad protein assay) per litre of BMGY was obtained. 
74 
4.4.1 Characterisation Of The Purified Inhibitor Peptide 
First, it was necessary to prove homogeneity of the purified 
inhibitor peptide ; tricine-SDS polyacrylamide g e l electropho r esis 
followed by silver staining gave rise to one protein band migrating 
with a molecular mass of less than 6.2kDa (Figure 28) . This is 
consistent with the value 3 . 498Da predicted from the amino acid 
sequence . 1 nmol of the protein was subjected to five cycles of N-
terminal s equencing and the expected sequence of CMCPI2* 
(NH2 -R-v- {c}-P-M-; C was not determined) was confirmed. 
, KDa 
.. I -17 
2 1 
-14.4 
_10.7 
-8.2 
-6.2 
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4.4.2 Discussion 
The Invitrogen Pichia pastoris Kit for the expression of foreign 
proteins has proven to be a good t ool in the production of the 
recombinant chimeric protein inhibitor . However, shake-flask cultures 
have the disadvantage that cell growth conditions are not easily 
controlled . Aeration and medium buffering could be inadequate for 
high culture density. The accumulat ion of yeast by-products of 
metabolism could have influenced t h e yield of the final product . 
The reverse phase HPLC chromatograms indicate that the secretion of 
the inhibitor peptide into the medi um was an effective first 
purificat ion step which separates p roduct from most other cellular 
components. 
The N-terminus of the inhibitor pep tide was sequenced and the results 
interpreted as showing that the pro tein had been correctly processed 
by endogenous yeast Kex2 like prote ases . But it still remains to be 
proven whe ther the rest of the pep t ide was authentically produced. 
Tricine-SDS polyacrylamide gel ana l ysis of the inhibitor peptide 
indicate t hat it was purified to homogeneity. 
4.4.3 Conclusion 
From this study on the effectivenes s of production of a foreign 
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inhibitor peptide in a bacterium and a yeast, it was clear that the 
yeast host was a better producer . However, the two expression systems 
can not be quantitatively compared du e to differences in experimental 
design. 
It remains t o be established if the putative multispecifi c inhibitor 
peptide is in fact active. This will b ring the design section to 
completion and will allow the hypothes es to be judged. 
Part 5 
Materials And Methods 
5.1 Suppliers Of materials 
Supplier 
Boehringer-Mannheim 
Pharmacia Fine Chemicals 
Pro mega 
Stratagene 
DNAZyme 
Sigma 
Biozyme Laboratories Ltd 
Boehringer-Mannheim 
Toso Hass 
BDH Laboratory Supplies 
Merck 
Macherey- Nagel , Dliren 
Difeo and Sigma 
R. Chauhan (UCT) 
Pei-Yin Ma (UCT) 
Jenni Poter (UCT) 
Materi al 
Restriction enzymes 
SuRE CUT Enzyme Buffers 
MonoQ HRl0/10 Anion Exchange HPLC Column 
Taq Track Sequencing Kit 
Taq I Ox buffer 
Taq DNA polymerase 
1 Ox Taq buffer 
DNA polymerase 
1 Ox DNA polymerase buffer 
IPTG, CsCI, RNAse A, X-gal, Trypsin, 
Tricine, Ampicillin, Agarose, and Chymotrypsin 
Enterokinase (EC 3.4.21.9) 
Nuclease Pl (EC3. l.30. I) 
RP HPLC Column (ODS-80TM) 
Acrylamide (sequencing grade) 
All other chemicals (analytical grade) 
NUCLEOBOND Ax JOO Kit 
Ingredients for yeast media 
pWM528 and JM83 
pMAL-pk, TB 1 
pHIL-SI , GSl 15 
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5.2 Recipes 
1) Luria Broth (LB: Luria-Bertani) [102) 
per litre 
Tryptone 
Yeast extract 
NaCl 
lOg 
Sg 
Sg 
adjust pH to 7.5 using l M NaOH 
2) Alkaline Lysis Buffers [103) 
Solution I: 
Glucose 
EDTA 
Tris/HCl pH 8 
SOmM 
lOmM 
25mM 
This solution is autoclaved and kept in the fridge 
Solution II : 
Na OH 
SDS 
Kept at room temperature 
Solution III : 
per lOOml 
K Acetate 
0.2M 
1% 
Glacial acetic acid 
water 
3) DNase free RNase preparation 
60ml SM 
l.Sml 
38.Sml 
RNase A is dissolved at 20 mg/ml in 0.3M sodium acetate (pH 5.5) and 
aliquoted into eppendorf tubes which are incubated in boiling water 
for 10 min. 
4) TE (Tris-EDTA) Buffer 
Tris (pH 8.0) 
Na2 EDTA 
5) TER Buffer (to make 10 ml) 
lO mM Tris 
lOmM 
lmM 
O.lml {lM Tris,pH 8 . 0} 
0.02ml{O.SM EDTA, pH 8.0 
0.02ml lOmg / ml RNase A 
l mM EDTA 
20µg/ml RNase A 
add sterile water to the 10 ml mark 
6) Preparation of phenol [102] 
To 500 ml of redistilled phenol add 0.5 ml of hydroxyquinoline and 
mix. Add 500 ml of 50 mm Tris base (pH 10.0), stir for 10 min and 
stand at room temperature to allow phases to separate. Remove the 
aqueous phase and replace it with t he same amount of 50 mM Tris (pH 
8.0) . Repeat the process once again. The equilibrated phenol can be 
stored at room 4°c under 50 mM Tris pH 8.0 
. J 
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7) PCR product phenol-chloroform extraction 
The PCR sample is made to 180 µL with TE, in an eppendorf. 20 µL of 
phenol i s added and the sample is mixed well. 200 µL of 
chloroform/ isoamylalcohol (24:1) is added and the sample is mixed 
again. The eppendorf is centrifuge d in a microfuge for Smin at 4°c. 
The top layer is carefully removed into a new eppendorf, avoiding the 
white interface layer. An equal v o lume of cold isopropanol and 1/10 
volume 3M sodium acetate is added to the sample. It is mixed and 
incubated on ice for 5 min, after which it is centrifuged in a 
microfuge for lOmin at 4°C. The sup ernatant is removed and the pellet 
is washed with 200 µL 70% ethanol (centrifuge for 2 min at 4°c with 
tube re-orientation) . The ethanol is removed, and the pellet is 
briefly dried in a Speedvac. The pellet is finally resuspended in TE . 
8) TBE (Tris-Borate - EDTA) 10 times concentrated 
Tris (pH 8.0) 
Boric acid 
EDTA 
0.89M 
0 . 89M 
0. 2M 
9) Denaturation solution for bridg e mutagenesis 
(10 times concentrated) 
Tris (pH 8 .0) 
KCl 
MgS04 
DTT 
SOmM 
lOOmM 
SOmM 
SmM 
10) DNA loading buffer 
Sucrose is dissolved to 40% in TE and a spatula tip of Bromophenol is 
added. 
11) Denaturation solution for bridge mutagenesis 
(Two times concentrated) 
KCl 20mM 
Tris/HCl (pH 8 . 0) 
MgSo4 
lOmM 
lOmM 
lmM DTT 
11) pMAL expression system buffers 
Column buffer: 
Tris/HCl (pH 7.4) 
NaCl 
EDTA 
Sodium azide 
DTT 
20mM 
200mM 
lmM 
lmM 
lmM 
12) Media for yeast growth, screen ing and induction of protein 
secretion 
a. YPD (for growth) 
To prepare a litre; 10 g of bacto yeast extract and 20 g of peptone 
are dis s olved in 900 ml distilled water and the mixture is autoclaved 
for 20 minutes. To this 100 ml of lOx dextrose (200 g of D-glucose 
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dissolved in 1000 ml water and a u toclaved) is added. The solution is 
kept at room temperature. 
b. MD (for screening) 
To prepare MD plates; 200 ml of autoclaved water was combined with 
3.75 g agar and the mixture was autoclaved. The mixture is allowed to 
cool to about 60°c. Thereafter, 2 5 ml of lOx YNB (33 . 5 g yeast 
nitrogen base lacking amino acids dissolved in 250 ml autoclaved 
water and then filter sterilized), 0.5 ml 500x biotin (20 mg of 
biotin in 100 ml water, filter sterilized) and lOx dextrose were 
added. The solution is then poured into sterile petri dishes. 
c. MM (for screening) 
MM. plates have the same composition as MD plates with the exception 
of the addition of methanol to 0.5% .. 
d. BMGY (for protein expression) 
To make a litre: 10 g of yeast ext ract, 20 g peptone and 700 ml water 
were combined, then autoclaved. Th e solution was then allowed to cool 
to room temperature prior to the a ddition of the following 
ingredients; 100 ml lOx yeast nit r ogen base, 2 ml 500x biotin, 100 ml 
lM phosphate buffer(pH 6.0), and 1 00 ml lOx GY (10% glycerol, 
sterile) 
e. BMMY (for induction of protein expression) 
The composition of this medium is similar to BMGY, except that it 
lacks lOx GY and contains 0.5% me t hanol. 
5.3 Methods 
5.3.1 Extraction (purification} of E. coli plasmid DNA 
and Pichia pastoris genomic DNA 
The metho d used for the isolation of plasmid DNA was adapted from the 
alkaline lysis method of Sambrook et al . [104] 
A) Large scale lysis by alkali 
+ 10 ml LB was inoculated with a loop of the desired clone from a -
70°c stock in a McCartney bott l e containing the appropriate 
antibiotic. Incubated overnight at 37°c with vigorous shaking. 
• 
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+ 500 ml of LB (containing 100 µg/ml antibiotic) in a 2L flask is 
then inoculated with 1 ml of the overnight culture and the mixture 
is incubated at 37°c overnight with shaking . 
+ The cells are harvested by centrifugation (20 min., 4°c) at 5000 
rpm in a JAlO rotor of a BECKMAN J 2-21 centrifuge. 
+ The superna tant is decanted and t h e pellet is resuspended in 10 ml 
solution I. 
+ Incubated on ice for 5 min. 
+ 10 ml of solution II is added, mix gently and let stand on ice for 
~ min. 
+ To this was added 10 ml of solution III and then followed with 
rigorous mixing . 
+ Clear off precipitate by centrifugation (20 000 rpm in a JA20 
rotor for 20 min., 4°c). The clear solution was aspirated off and 
placed in a clean tube. 
+ Plasmid DNA was precipitated by adding an equal volume of 
• 
isopropanol and incubation at -20 °c for 30 min. 
The DNA is washed with 70% ethanol, centrifuged (10 000 rpm, 0 4 c, 
10 min.) . The supernatant is decan ted and the pellet is air dried 
briefly, a nd resuspended in 4 ml TE. 4.5 g CsCl was added and 
dissolved and 150µ1 EtBr (lOmg/ml) added. 
+ The preparation was centrifuged at 55 000 rpm at 20°c for 16 hrs . 
The resultant plasmid band was extracted and the EtBr removed 
through phase separation using isoamylalcohol. CsCl was removed by 
dialysis against TE buffer for 3 hrs. 
To the mixture, 3 volumes of ethanol are added followed by incubation 
at -20°c for 1 hr. The DNA pellet is collected by centrifugation (20 
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000 rpm, 10 min., JA-20 rotor), wa shed in 70% ethanol, and air dried. 
The pellet is finally dissolved i n 1 ml TE . 
B) One step 'miniprep' method for the isolation of plasmid DNA 
The method used was as reported by Kamal Chowdhury [105] 
0 Take 0.5 ml of overnight E . Coli culture in an eppendorf. 
0 Add 0 . 5 ml of phenol : chloroform: isoamylalcogol (25:24 : 1) 
0 Mix b y vortexing at maximum speed for 1 min. 
0 Centrifuge at 12 000 rpm for 5 min. in a microfuge. During the 
spin pre pare eppendorfs with isopropanol . After the 
centrifugation, carefully remove 0 . 45 ml of the upper aqueous 
phase l e aving the interface und isturbed and add it to the 
isopropanol. Mix well and spin immediately at 12 000 rpm for 5 
min . 
0 Pour o f f the supernatant, add carefully 0 . 5 ml of 70 % ethanol to 
the side of the tube and pour o ff. Repeat the washing once more. 
Vacuum d ry the pellet and suspend in 20 to 100 mi crol i ters o f TER 
buffe r . About 5-10 microliters of this DNA can be cleaved with 
appropriate restriction enzyme (s) for analysis. 
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C) Nucleobond AX PC-Kit 100 for t he purification of plasmids 
The procedure suggested by the supplier was followed. Buffers were 
also provided by the supplier . 
• Volume o f E . Coli overnight cul ture; lOOml . 
• The provided cartridge is equi l ibrated with buffer N2 (2ml) 
• Bacterial cells are collected by centrifugation and the r esul t ant 
pelle t is resuspended carefully in buffer Sl (4 ml) . 
• 4 ml o f buffer S2 is added . The suspension is mixed gently and 
incubated at room temperature f or 5 minutes. 
• Buffer S3(4ml) is added, the s u spension is mix ed gently by 
invert i ng the tube 6-8 times un til a homogenous suspension is 
formed . The suspension is incubated at on ice for 5-10 minutes a nd 
centr i f uged at high speed (>10 000 rpm) at 4°c for 38 minutes. 
• The s upernatant is removed care fully from the white precipitate 
and l oad e d on the NUCLEOBOND AX cartridge, equilibrated with 
buffer N2 . 
• The cartr i dge is washed with 2 times 4 ml buffer N3. 
• The p lasmid DNA is e luted with buffer NS (2ml) . 
• The purif ied plasmid DNA is pre cipitated with 0.8 volume s of 
isopropanol, preequilibrated t o room temperature, and centrifuged 
at hig h s peed (>10 000 rpm) at 4°c . The DNA is washed in 70% 
ethano l, briefly air dried and redissolved in appropriate amount 
of TE buffer. 
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D) Isolation of P. Pastoris genomic DNA 
The method used in this work was f irst reported by Hoffman, c.s. and 
Winston, F. [104a] 
* 
* 
Grow 10 ml yeast cultures in YPD medium to saturation. 
Harvest cells for 5 min at 5 00 0 rpm and resuspend in 0 . 5 ml 
water . 
* Decant the supernatant and brie fly vortex the tube to resuspend 
the pellet in the residual liqu id. 
* Add 200 ~tl of the following rea ction mixture (25 Triton X-100, 1% 
SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA), and vortex 
briefly . 
* Add 0 . 2 ml phenol:Chloroform:i s oamylalcohol (25:24:1). Then add 
0.3 g a cid-washed glass beads a nd vortex for three minutes . 
* Add 0. 2 ml TE and spin for 5 mi n. at 13 000 rpm. Transfer aqueous 
supernatant into a new tube and phenol/chloroform this mixture two 
times . Precipitate the DNA by a dding 1.0 ml of absolute ethanol 
and mi x. 
* Centrifuge for 2 min. At 13 00 0 rpm, then resuspend pellet in 0.4 
ml TE buffer. 
* Add 10 µl 4M ammonium acetate (pH 5.5) plus 1 . 0 ml ethanol and 
invert tube to mix. Spin for 2 min., dry pellet and resuspend in 
50 µl TE. 
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5.3.2 Plasmid Digests 
High, medium and low salts buffers s upplied as a 10 x stock were used 
for most digests. Between 1 and 2 µg of plasmid DNA were digested in 
volume of 10 to 20 µl with 1 to 3 units of restriction enzyme per 
microgram of DNA . Digests were perfo rmed at the optimal temperature 
for the particular enzyme for 2 hrs or overnight . Reaction mixtures 
were incubated in a water bath set a t the required temperature. Note 
that digests with Nuclease Pl were carried out for 25 min. in 0 . 02 M 
EDTA at 3 7°C. 
In the case of double digest, a common buffer in which both enzymes 
are active was chosen and the diges t was done overnight. 
5.3.3 Gel electrophoresis 
1) Agarose 
DNA preparations were routinely ana lyzed by agarose gel 
electrophoresis, using a flatbed a pparatus and 0.8, 1.0 and 3.0 % 
agarose in TBE buffer (pH 8.0) cont aining EtBr at 0.5 µg/ml. The 
running buffer(l x TBE) in which t h e gel was submerged also contained 
EtBr at the same concentration . Ge l loading buffer containing sucrose 
and bromophenol blue as a tracking dye was added to the samples 
before loading, and electrophoresi s was carried out at 4-8 volts/cm 
for 2-5 hrs. 
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2) SDS Polyacrylamide gel electrophoresis {SDS PAGE) 
Periplasmic extracts and purified fus ion proteins were 
electrophoresed on 13%/14% SDS PAGE. 15 cm long gels were run 
consisting o f a± 2 cm stacking gel a nd 12 cm of separating gel. 
Samples were dissolved by boiling for 3 minutes in an appropriate 
volume of SDS sample buffer containing 20µ1/ml of 2-mercaptoethanol. 
Gels were run at 10 mA until the bromophenol blue of the loading 
buffer had entered the stacking gel then current increased to 18 mA, 
and then ran until the bromophenol h a d just run off the bottom of the 
gel. 
3) Purification Of Small DNA Fragments From Non-
Denaturing Polyacrylamide Gels 
• Double digestions of plasmids carrying insert DNA for subcloning 
were loaded on 12% 15 cm long polyacrylamide gels. Usually, 5 µg 
DNA was l o aded per well and elect r ophoresis was done in vertical 
set ups using TBE at one times the strength as a running buffer. 
The electrophoresis was conducted for 2-3 hrs at 2 V/cm . Samples 
were made 10% in sucrose before l oading and a separate lane was 
loaded with loading buffer containing bromophenol blue as a 
tracer. 
• After the electrophoresis, the ge l plates were detached from the 
tank and the plates were separated ensuring that the gel was left 
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on one plate . The attached gel was stained for 20 minutes in 0.5 
µg/ml EtBr 
• Under a longwave UV light lamp, the DNA bands were cut out with a 
razor b lade. 
• The gel pieces were placed in 1 . 5 ml tubes which contained elution 
buffer (0 . 5M ammonium acetate, l mM EDTA) , sufficient to cov er the 
gel pieces . 
• To elute the DNA, the tubes are incubated at 37°c with overnight 
shaking. 
• Supernatants were pipetted off a nd DNA fragments were precipitated 
with 2 v olumes of ethanol, chil l ed at -20°C for 30 min. The 
fragments were recovered by cent rifugation( 12 OOOrpm, 4°c, 10 
min.) 
• Pellet s were rinsed in 7 0% ethanol , dried and r esuspended in TE 
buffer . 
4) Tricine-SDS PAGE 
Small prote ins were dissolved i n SDS loading buffer and loaded on 14% 
gels including a stacking gel as de scribed by Herman Schagger and 
Gebhard von Jagow [106] and the pro tein bands were stained by silver 
staining . 
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5.3.4 Cloning 
1) Ligation 
100 µg of digested vector DNA was added to 2x equimolar, 3x equimolar 
and 4x equimolar insert DNA. Water was added to 8 µl and 1 µl of lOx 
bacteriophage T4 DNA ligase buffe r was added. Then 5 units of T4 DNA 
ligase was added . The reaction wa s incubated at 4°C overnight. 
2)Transformations 
a. Competence induction. Fresh ove rnight culture in LB from a single 
colony (JM83 or TBl) off a fresh p late was grown. 1 ml of this was 
added to 100 ml LB and grown to A600 ± 0 . 5 . The cells were incubated 
on ice for 15 minutes. 40 ml of t h is was centrifuged at 4 000 rpm in 
a JA20 rotor of a Beckman J2-21 c e ntrifuge at 4°c for 5 min. And 
immediate ly dissolved in 8 ml of 0 . 1 M CaC1 2 at 4°c . This was 
recentrifuged as above and resuspended in and the same solution and 
kept on ice for 45 minutes then harvested as before and redissolved 
in 1.6 ml of the same calcium chloride solution, then kept on ice. 
b. Transformation. The ligation mixture (5µ1) was made to 100 µl with 
water and incubated on ice in an eppendorf . To this was added 200 µl 
competent cells and stood on ice for 15 minutes. After which, it was 
directly transferred to a water b ath at 42°c for 3 minutes, then back 
to ice for 5 ml. To this was adde d 0.8 ml LB and incubated at 37°C 
with shaking for 30 minutes. The cells were spun down and resuspended 
in 100 µl LB of which all was plated on LB plates containing 100 
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µg/ml ampicillin. The plates were kept at 37°C in an upside-down 
position overnight to allow growth of recombinants . 
5.3.5 DNA sequencing 
DNA was sequenced using the Taq TrackRM Sequencing System 
supplied by Promega according to the manufacturers instructions. In 
all cases double stranded DNA was used a s a template. 10 µg of 
template DNA (CsCl purified or Nucleobon d purified) was diluted to 18 
µl with sterile double distilled water a nd 2 µl of 2 M NaOH added. 
This was incubated at 37°C for 6 min. The solution was neutralized by 
the addition of 4 µl sodium acetate (pH 5.5) and the DNA precipitated 
by the addition of 150 µl ice cold absolute ethanol. It was then 
centrifuged for 20 min in a microfuge a t 4°C. The resultant pellet 
was washed in 70 % ethanol and briefly a i r dried. The DNA was then 
ready for priming for which the manufac t urer's protocol was used. The 
sequencing of a particular DNA template made use of forward and 
reverse primers specific for that partic ular vector . 
Products were electrophoresed at 86W on a 6% polyacrylamide 
sequencing gel, that was kept at 42°C us i ng a water jacket. The gel 
was dried and placed in an autoradiograp h cassette with a sensitized 
X-ray film. The autoradiograph was expos ed overnight at -70°C, and 
then developed . 
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5.3.6 Oligonucleotide Synthesis 
a. Synthesis. Oligonucleotides were synthesized with nucleoside-o-(2-
cyanoehyl)-N,N- diisopropyl phosphoramidites. These and other reagents 
for synthesis were from Biosearch. Synthesis was performed on a model 
6500 Autogen™ DNA synthesizer in a glass column containing 1 µmole 
(for the long synthesis oligos) and 0.2 µmole (for short oligos such 
as primers) of a n appropriate 5'-0-dimethoxytrityl deoxynuleoside-3 ' -
0-succinyl-derivatized 1000 Angstrom cont rol pore glass support at a 
loading of 18 µmol/g. 
b. Preparation of oligonucleotides for purification by anion exchange 
chromatography 
The synthesis p r oducts are first removed from the support medium by 
cleavage in concentrated ammonia; add 1 ml 32% ammonia and allow to 
stand at room temperature for 2 hrs . Cent rifuge in a microfuge and 
remove the supe rnatant into a fresh eppendorf tube . Seal the tube 
tightly and incubate at +70°c for 1 hr. Precipitate the 
oligonucleotide in butanol (lml butanol for 100 µl oligo) 
c. Purification of oligonucleotides 
The precipitated oligonucleotide is resus pended in buffer A (SOmM 
LiCl, lOmM NaOH, pH 12.0) . The sample was run over a MonoQ HRl0/10 
ion exchange HPLC column. A LiCl concentration gradient (SOmM to 3M) 
was used to elute the oligonucleotides. Fractions containing the 
desired oligonucleotide were detritylated to remove the DMTr group. 
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The desired HPLC samples were precipita ted overnight at -70°c with 6 
volumes of acetone/ethanol (3 : 1). The s ample was centrifuged at 20 
000 rpm, at 4 °c. The pellet was resuspeded in 100 µl water and 
reprecipitated with 9 volumes of butano l. 500 µl cold, concentrated 
ammonia was added to the pellet and the n evaporated in a Speedvac. 
The pellet wa s dissolved in 100 µl 80% acetic acid and left at room 
temperature f or 1 hr. The DNA was precipitated with 9 volumes of 
butanol and resuspended in TE buffer. 
5.3.7 Bridge Mutagenesis Synthes i s Of A Gene 
Three aliquots of 50 ng of plasmid linearized with Smal restriction 
enzyme was mixed with complementary oligonucleotide at 10 fold, 100 
fold and 1000 fold molar excesses. To this was added 15 µl of 
denaturation buffer (section 5.2) and the total volume was made up to 
30 µl with ste rile water. The mixture was boiled for 3 min. And 
allowed to coo l at room temperature for 5 minutes. The cooled mixture 
was centrifug e d to collect condensate a nd placed on ice. To eac h 
tube, 100 µl competent JM83 [ara, ~( l a c-pro ) , strA, thi, ~BOd lacz 
MlS] cells were added. Transformed cells were plated on LB containing 
100 µg/ml Of ampicillin and 20 µg/ml X-gal . Transformants were 
selected according to the appropriate c hange in colour from that of 
the parental on the same medium. 
5.3.8 Gene Expression 
Bacterial strains containing the gene t o be expressed were grown at 
37°c with shaking to A60 0 0.3-0.6 in LB with ampicillin. Cells were 
ii 
I 
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harvested by centrifugation (4 000 rpm, JA20 rotor) under sterile 
conditions and resuspended in fresh sterile LB at 37°c, containing 
ampicillin (100 µg/ml)and then induced by adding IPTG to a final 
concentration of 0 . 3 mM and shaking f o r a further 3 hrs at 37°c. 
The cells were pelleted by centrifugat ion (4 000 rpm, lOmin, 4 °c ), 
and resuspended in 30 mM TrisHCl, 20% sucrose , pH 8.0 (8 ml for each 
0.1 g cells wet weight). Incubate for ten minutes at room 
temperature . Cells were then centrifug ed (8 000 rpm, 4°c, 10 min . ) 
and dissolved in ice cold 5 mM MgS04 (8 ml for each 0.1 g cells wet 
weight). The s uspension was mixed gent ly for 10 min. in an iced water 
bath. After that, it was centrifuged a s above and the fusion protein 
was isolated from the resultant supernatant. 
I ~ 
5.3.9 The Maltose Binding Prote i n Purification System 
Two 500 ml cultures of E. Coli TBl(CMCPI2•) were grown to mid log 
phase and induced with IPTG. After 3 h rs post induction, the cells 
were harvested and were subjected to cold osmotic shock as mentioned 
above. The supernatant was diluted by half in column buffer, then 
loaded to a cross -linked amylase column which had been equilibrated 
in column buffe r. A washing step with 100 ml of column buffer was 
carried out, followed by elution of t h e fusion protein with 10 mM 
maltose. Approximately 12 fractions we re collected, dialyzed and 
concentrated by freeze drying. The fusion protein was then 
electrophoresed on a 13% SDS polyacrylamide gel. 
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5.3.10 Fusion Protein Digestion With Enterokinase 
The protein preparation was made 50mM Tris, pH 7.5 and 25 µg was 
incubated with 0 . 6 µg enzyme at 37°c f or 24 hrs. 
5.3.11 PCR Screening Of Transformants 
a) E. Coli colonies. Colonies were pic ked from the plates into 
separate test tubes containing 10 ml LB broth and grown overnight at 
37°C with sha king. A 1 / 20 dilution was made into 100 µl of water and 
boiled for 5 min . 25 ml of the boiled sample was added to an equal 
volume of Stratagene ix PCR buffer (1 0 mM Tris/HCL, pH 8.8, 50 mM 
KCl, 1.5 mM MgC1 2 , 0 . 01% gelatin) cont aining 0.2 µM of each dNTP, 20 
pmol of each plasmid primer, and 0.005% Tween 20 . 1 unit of 
Stratagene Taq polymerase was added t o the combined sample, which wa s 
the overlaid with 30 µl paraffin oil. 30 cycles of 10 sec at 92 °C, 30 
sec at 55°C a nd 6 0 sec at 72 °C were performed, with an additional 5 
min. Extension at 72 °C after the last cycle. Products were visualized 
by agarose g e l electrophoresis on a 3% gel containing TBE buffer and 
EtBr, or by PAGE on a 12% gel and visualized after staining in EtBr. 
B) Pichia pastoris clones. Total genomic DNA of recombinants was used 
in PCR; 0.5 ~tg of template DNA in a volume of 25 µl was added to the 
PCR buffer me ntioned above. The PCR reaction and v isualization of 
products was carried out as mentioned . 
I 
·/' 
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5.3.12 PCR Amplification 
1 ng of template DNA was added to 5 µ l lOx Dynazyme buffer containing 
0.2 µM of each dNTP, 10 pmol of each p rimer and the volume was made 
to 50 µl with sterile water. 2.5 unit s of Dynazyme DNA polymerase was 
added to the s ample which was overla i d with 30 ~tl of paraffin oil. 
30 cycles of 20 sec At 94 °C, 30 sec at 50°C, and 50 sec at 72°C were 
performed, with an additional 180 sec extension at 72 °C after the 
last cycle. 
5.3.12 Amino Acid Sequence Analy sis 
N-terminal sequence analysis was perfo rmed on a gas-liquid solid 
phase sequenc er constructed by Hewick et al. [107} and slightly 
modified as de s cribed by Brant et al. [108). The reagents, solvents 
and degradation cycle used have been published in the above 
references. The converted PTH amino a c ids were identified by an 
isocratic HPLC system on a 3 x 250mm 3µ Lichrospher C18 (Bischoff) 
column as des cribed by Lottspeich [10 7b] . 
5.3.13 Amino Acid Composition Analysis 
Gas phase acid hydrolysis was performe d on sample of 5-10 nmols in 
acid washed, pyrolised test tubes. 5 . 7 M HCL and 0.1% phenol was 
utilized in an evacuated vessel. The hydrolysis was carried out at 
110°c for 24 hrs. 
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A standard mixture of 10 nmols of fre e amino acids was hydrolyzed 
together with the samples and used fo r quantitation. Norleucine was 
added as an internal standard 
For detection purposes, the hydrolysates were derivatised using the 
Dabsyl method (108, 108.a], and separated by reverse phase HPLC. 
I 
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